_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
720440501,5/12/2015 13:37:06,1634907174,5/12/2015 13:36:53,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 14:14:18,1634921600,5/12/2015 14:13:00,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 14:27:22,1634927349,5/12/2015 14:27:12,false,instagc,1,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],PSITTACOSIS caused by C PSITTACI,n/a,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 14:34:31,1634930602,5/12/2015 14:34:12,false,elite,1,31913360,USA,DE,"",108.59.8.217,[SYMPTOM],[SYMPTOM],PSITTACI,;l;;;,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 14:35:39,1634931165,5/12/2015 14:34:32,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 14:37:32,1634932134,5/12/2015 14:37:12,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],PSITTACOSIS caused by C PSITTACI,n/a,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 14:38:32,1634932700,5/12/2015 14:37:53,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused,N/A,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 14:41:56,1634934062,5/12/2015 14:41:44,false,neodev,1,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 14:43:46,1634934858,5/12/2015 14:43:34,false,clixsense,1,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Treatment PSITTACOSIS (ornithosis) caused C PSITTACI,na,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 15:15:55,1634961497,5/12/2015 15:15:32,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],caused by,N/A,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 15:32:32,1634982242,5/12/2015 15:32:03,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],caused by,n/a,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 15:33:34,1634983598,5/12/2015 15:33:13,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],PSITTACOSIS caused by C PSITTACI,N/A,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 15:41:26,1634993258,5/12/2015 15:40:53,false,prodege,1,14571439,CAN,ON,Toronto,142.20.20.193,[SYMPTOM],[SYMPTOM],caused by,N/A,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 15:42:17,1634994336,5/12/2015 15:41:54,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],Treatment,n/a,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440501,5/12/2015 15:43:57,1634996612,5/12/2015 15:42:47,false,prodege,1,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],PSITTACOSIS caused by C PSITTACI,N/A,13,49,1,23,59,TWrex-cause,810608-FS1,Treatment of PSITTACOSIS (ornithosis) caused by  C PSITTACI,PSITTACOSIS,C PSITTACI
720440502,5/12/2015 13:32:18,1634904983,5/12/2015 13:31:43,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment of,N/A,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 13:35:53,1634906671,5/12/2015 13:35:35,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 14:11:03,1634920460,5/12/2015 14:10:39,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment,N/A,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 14:26:03,1634926778,5/12/2015 14:25:36,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],FLUCONAZOLE in the treatment of NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,n/a,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 14:30:23,1634928617,5/12/2015 14:27:50,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 14:33:11,1634929910,5/12/2015 14:33:02,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[CAUSES],[CAUSES],pulmonary,cdc,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 14:33:35,1634930144,5/12/2015 14:33:14,false,prodege,1,2145087,USA,NY,New York,107.107.63.230,[TREATS],[TREATS],in the treatment of,N/A,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 14:34:03,1634930348,5/12/2015 14:33:02,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 14:34:55,1634930830,5/12/2015 14:34:25,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],FLUCONAZOLE in treatment of NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,n/a,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 14:40:37,1634933488,5/12/2015 14:40:19,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 14:42:12,1634934257,5/12/2015 14:41:50,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Catanzaro Galgiani Levine FLUCONAZOLE treatment chronic pulmonary NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,na,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 15:13:48,1634958822,5/12/2015 15:13:17,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment,N/A,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 15:29:43,1634978634,5/12/2015 15:28:42,false,clixsense,1,12843982,AUS,08,Perth,180.216.79.226,[TREATS],[TREATS],FLUCONAZOLE treatment NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,I didn't select NONE.,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 15:30:23,1634979556,5/12/2015 15:30:02,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],FLUCONAZOLE in the treatment of NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,N/A,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440502,5/12/2015 15:30:53,1634980188,5/12/2015 15:30:29,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],in the treatment of,n/a,98,44,-1,141,55,TWrex-cause,800929-FS1,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE
720440503,5/12/2015 16:03:21,1635018886,5/12/2015 16:02:43,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],FANCONI SYNDROME with HYPOPHOSPHATEMIA,N/A,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 17:44:42,1635080703,5/12/2015 17:44:04,false,instagc,1,24252915,GBR,K6,Portsmouth,89.240.160.95,[SYMPTOM],[SYMPTOM],In SYNDROME present with HYPOPHOSPHATEMIA,N/a,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 18:47:34,1635164990,5/12/2015 18:47:19,false,neodev,1,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 18:53:00,1635173232,5/12/2015 18:52:39,false,clixsense,1,24329110,USA,FL,Tampa,66.192.17.130,[SYMPTOM],[SYMPTOM],present with,n/a,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 18:56:36,1635178458,5/12/2015 18:56:00,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],present,n/a,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 19:04:35,1635190720,5/12/2015 19:02:05,false,neodev,1,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],present,N/A,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 19:13:56,1635207677,5/12/2015 19:11:41,false,elite,1,30064988,GBR,H3,Leeds,92.29.156.184,[SYMPTOM],[SYMPTOM],present with laboratory abnormalities,N/A,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 19:37:32,1635252601,5/12/2015 19:36:12,false,neodev,1,32216655,NLD,07,Amsterdam,145.100.72.168,[PART_OF],[PART_OF],present with,n/a,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 19:49:05,1635263296,5/12/2015 19:48:43,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],present with the laboratory abnormalities,n/a,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 20:02:38,1635274791,5/12/2015 20:02:04,false,instagc,1,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FANCONI SYNDROME adults present with HYPOPHOSPHATEMIA,N/A,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 20:14:02,1635283647,5/12/2015 20:11:32,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",N/A,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 20:45:59,1635304917,5/12/2015 20:44:50,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],adults present with the laboratory abnormalities of,N/A,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 20:47:05,1635305758,5/12/2015 20:44:50,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,[ASSOCIATED_WITH] [NONE],"[ASSOCIATED_WITH]
[NONE]",adults present with the laboratory abnormalities,N/A,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 20:57:09,1635311809,5/12/2015 20:56:47,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,[MANIFESTATION],[MANIFESTATION],present,n/a,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440503,5/12/2015 21:13:26,1635322425,5/12/2015 21:12:24,false,elite,1,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,Not clear if any relation exists.,124,12,1,139,28,TWrex-cause,814097-FS1,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME
720440504,5/12/2015 18:50:21,1635169167,5/12/2015 18:50:08,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 18:56:57,1635179211,5/12/2015 18:56:37,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[SYMPTOM],[SYMPTOM],rest PAIN,n/a,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 19:09:53,1635198825,5/12/2015 19:09:22,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],develop,N/A,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 19:22:33,1635230122,5/12/2015 19:21:32,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[OTHER],[OTHER],may develop,N/A,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 19:50:59,1635264658,5/12/2015 19:49:05,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[SYMPTOM],[SYMPTOM],Symptoms of may develop,n/a,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 19:53:48,1635266930,5/12/2015 19:53:18,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[MANIFESTATION],[MANIFESTATION],or rest,n/a,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 20:08:21,1635278895,5/12/2015 20:07:32,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Symptoms of UNSTABLE ANGINA or rest PAIN,N/A,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 20:25:10,1635291636,5/12/2015 20:23:18,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SYMPTOM]","Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",N/A,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 21:08:32,1635319367,5/12/2015 21:08:10,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],Symptoms,n/a,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 21:19:26,1635325995,5/12/2015 21:18:27,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",or,N/A,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 22:09:01,1635356247,5/12/2015 22:07:35,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[NONE],[NONE],N/A,"While they may be symptoms of a condition, they are not actually related to each other per se.",68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 22:13:55,1635360070,5/12/2015 22:13:16,false,clixsense,1,23197581,NLD,11,Den Haag,82.217.5.55,[OTHER],[OTHER],or or,N/A,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 22:36:20,1635379136,5/12/2015 22:35:54,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],Symptoms of UNSTABLE ANGINA PAIN,N/A,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 22:36:32,1635379323,5/12/2015 22:35:50,false,instagc,1,13763729,USA,NC,Apex,75.182.91.110,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",Symptoms of UNSTABLE ANGINA PAIN,N/A,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440504,5/12/2015 22:56:58,1635395177,5/12/2015 22:56:02,false,clixsense,1,19294877,USA,MA,Boston,71.174.182.224,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]","Symptoms UNSTABLE ANGINA ischemic stroke, or rest PAIN may develop when plaques rupture",n/a,68,12,1,71,27,TWrex-cause,813164-FS1,"Symptoms of UNSTABLE ANGINA or infarction, ischemic stroke, or rest PAIN in the limbs may develop when unstable plaques rupture and acutely occlude a major artery, with superimposition of thrombosis or embolism.",PAIN,UNSTABLE ANGINA
720440505,5/12/2015 14:41:47,1634934027,5/12/2015 14:41:26,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[LOCATION],[LOCATION],sodium,hj,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 14:49:35,1634937427,5/12/2015 14:49:17,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],adequately controlled,N/A,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 15:02:55,1634946795,5/12/2015 15:02:29,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CATAPLEXY controlled with SODIUM OXYBATE.,n/a,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 15:08:36,1634952676,5/12/2015 15:06:38,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],are adequately controlled with,N/A,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 15:26:49,1634975205,5/12/2015 15:26:30,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],adequately controlled with,N/A,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 15:59:47,1635016881,5/12/2015 15:59:13,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],CATAPLEXY are controlled with SODIUM OXYBATE.,N/A,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 17:26:38,1635062081,5/12/2015 17:25:19,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],are adequately controlled with,N/A,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 17:41:24,1635077048,5/12/2015 17:40:52,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[PREVENTS],[PREVENTS],CATAPLEXY adequately controlled with just SODIUM,N/a,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 17:46:45,1635082790,5/12/2015 17:46:23,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],patient required modafinil some patients daytime sleepiness CATAPLEXY adequately controlled with SODIUM OXYBATE.,na,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 18:45:44,1635161994,5/12/2015 18:45:25,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 18:51:28,1635170802,5/12/2015 18:50:47,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],adequately controlled,n/a,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 18:53:22,1635173759,5/12/2015 18:52:43,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],controlled,n/a,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 18:59:51,1635183670,5/12/2015 18:58:52,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],controlled,N/A,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 19:08:00,1635195987,5/12/2015 19:07:35,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[TREATS],[TREATS],adequately controlled,N/A,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440505,5/12/2015 19:32:05,1635245361,5/12/2015 19:31:09,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],adequately controlled,n/a,160,206,-1,168,220,TWrex-cause,804970-FS1,"Although this patient still required modafinil for daytime sleepiness after initation of sodium oxybate, in some patients both excessive daytime sleepiness and CATAPLEXY are adequately controlled with just SODIUM OXYBATE.",CATAPLEXY,SODIUM OXYBATE
720440506,5/12/2015 17:48:01,1635084174,5/12/2015 17:47:16,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[NONE],[NONE],N/a,Not related in any way in the sentence.,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 18:48:52,1635167076,5/12/2015 18:48:39,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 18:55:06,1635176195,5/12/2015 18:54:40,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],may lead to,n/a,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 19:07:18,1635195009,5/12/2015 19:06:52,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],lead to,N/A,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 19:18:31,1635219632,5/12/2015 19:17:25,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[SIDE_EFFECT],[SIDE_EFFECT],may lead to,N/A,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 19:44:37,1635260101,5/12/2015 19:43:51,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],may lead to hypertension.,n/a,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 19:52:00,1635265416,5/12/2015 19:51:34,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],the drugs,n/a,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 20:05:34,1635276948,5/12/2015 20:04:13,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PREGNANCY and COCAINE,N/A,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 20:18:48,1635287021,5/12/2015 20:17:41,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]","Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",N/A,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 20:49:37,1635307196,5/12/2015 20:48:55,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and the use of,N/A,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 21:06:36,1635318127,5/12/2015 21:06:02,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],also,n/a,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 21:08:45,1635319465,5/12/2015 21:07:44,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",the use of certain drugs,N/A,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 21:16:04,1635324095,5/12/2015 21:15:07,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 21:44:29,1635339454,5/12/2015 21:42:29,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[NONE],[NONE],N/A,"While pregnancy and cocaine may lead to hypertension, they are not related to one another.",23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440506,5/12/2015 21:47:53,1635341382,5/12/2015 21:46:54,false,clixsense,1,6338946,CAN,QC,Montr√©al,209.197.141.151,[NONE],[NONE],N/A,Pregnancy OBESITY is being discussed so there is no relation between just pregnancy and cocaine,23,78,-1,31,85,TWrex-cause,803089-FS1,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE
720440507,5/12/2015 20:06:58,1635277897,5/12/2015 20:06:19,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],for the treatment of,n/a,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/12/2015 20:16:52,1635285664,5/12/2015 20:16:26,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],HIGH DOSE FLUCONAZOLE treatment of CRYPTOCOCCAL MENINGITIS:,N/A,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/12/2015 20:43:38,1635303437,5/12/2015 20:42:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS:,N/A,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/12/2015 21:22:43,1635328078,5/12/2015 21:20:12,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/12/2015 21:32:22,1635333293,5/12/2015 21:32:06,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],for the treatment of,N/A,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/12/2015 22:45:10,1635385787,5/12/2015 22:44:45,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],HIGH DOSE FLUCONAZOLE treatment of CRYPTOCOCCAL MENINGITIS:,N/A,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/12/2015 22:45:25,1635386001,5/12/2015 22:44:18,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],HIGH DOSE FLUCONAZOLE for the treatment of CRYPTOCOCCAL MENINGITIS:,N/A,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/13/2015 00:19:48,1635454651,5/13/2015 00:17:47,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Nussbaum JC, Jackson A, Namarika D Combination HIGH DOSE FLUCONAZOLE of a randomized trial in Malawi.",N/A,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/13/2015 00:33:35,1635464091,5/13/2015 00:33:11,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[TREATS],[TREATS],HIGH DOSE FLUCONAZOLE for treatment of CRYPTOCOCCAL MENINGITIS:,n/a,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/13/2015 00:34:38,1635464928,5/13/2015 00:34:18,false,elite,1,31848723,USA,"","",155.94.185.254,[SYMPTOM],[SYMPTOM],DOSE FLUCONAZOLE CRYPTOCOCCAL MENINGITIS:,N/A,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/13/2015 01:34:21,1635500323,5/13/2015 01:32:40,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],for the treatment of,n/a,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/13/2015 02:09:57,1635519890,5/13/2015 02:09:36,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for the treatment of,N/A,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/13/2015 02:58:41,1635542710,5/13/2015 02:57:41,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],compared with fluconazole monotherapy for the treatment of,no comment,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/13/2015 03:07:11,1635546379,5/13/2015 03:06:48,false,prodege,1,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],HIGH DOSE FLUCONAZOLE monotherapy treatment CRYPTOCOCCAL,n/a,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440507,5/13/2015 03:16:11,1635550574,5/13/2015 03:15:24,false,bitcoinget,1,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],for the treatment,n/a,151,70,-1,173,91,TWrex-cause,800099-FS1,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE
720440508,5/12/2015 14:42:08,1634934205,5/12/2015 14:41:59,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[CAUSES],[CAUSES],seizure,hghhg,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 14:49:49,1634937549,5/12/2015 14:49:37,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 15:03:28,1634947313,5/12/2015 15:02:59,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],SEIZURE or EPILEPSY,n/a,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 15:09:44,1634953944,5/12/2015 15:08:37,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],diagnosis,N/A,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 15:28:37,1634977369,5/12/2015 15:26:50,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[MANIFESTATION],[MANIFESTATION],first or an early diagnosis of,N/A,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 16:00:54,1635017588,5/12/2015 15:59:49,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SEIZURE or EPILEPSY,N/A,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 17:27:36,1635062733,5/12/2015 17:26:40,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],or an early diagnosis,N/A,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 17:42:41,1635078518,5/12/2015 17:41:32,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[PART_OF],[PART_OF],"risks for seizure recurrence, SEIZURE EPILEPSY",N/a,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 17:47:43,1635083904,5/12/2015 17:46:47,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"group patients, diverse risks seizure recurrence, compared early deferred AED treatment after SEIZURE early diagnosis EPILEPSY",na,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 18:46:24,1635163018,5/12/2015 18:45:58,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 18:51:53,1635171487,5/12/2015 18:51:29,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[SYMPTOM],[SYMPTOM],treatment after an early diagnosis,n/a,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 18:54:58,1635175970,5/12/2015 18:53:24,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 19:01:08,1635185610,5/12/2015 18:59:53,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 19:09:46,1635198590,5/12/2015 19:08:01,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[OTHER],[OTHER],compared,N/A,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440508,5/12/2015 19:34:28,1635248451,5/12/2015 19:32:06,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],compared SEIZURE or an early diagnosis of EPILEPSY,n/a,178,211,1,184,219,TWrex-cause,814531-FS1,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY
720440509,5/12/2015 20:18:12,1635286553,5/12/2015 20:17:26,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],AMPHOTERICIN B with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,N/A,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/12/2015 20:46:06,1635305008,5/12/2015 20:44:50,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,N/A,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/12/2015 21:23:56,1635328837,5/12/2015 21:23:13,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],formulation),n/a,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/12/2015 21:33:45,1635333921,5/12/2015 21:32:52,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],in adolescents with,N/A,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/12/2015 22:46:25,1635386691,5/12/2015 22:45:47,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],AMPHOTERICIN B in EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS:,N/A,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/12/2015 22:47:32,1635387583,5/12/2015 22:46:20,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],AMPHOTERICIN B infected adolescents with EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,N/A,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/13/2015 00:23:11,1635456714,5/13/2015 00:21:29,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],AMPHOTERICIN B in HIV infected adolescents with EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS:,N/A,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/13/2015 00:35:32,1635465519,5/13/2015 00:35:12,false,elite,1.0,31848723,USA,"","",155.94.185.254,[ASSOCIATED_WITH],[ASSOCIATED_WITH],AMPHOTERICIN EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS:,N/A,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/13/2015 00:51:20,1635477128,5/13/2015 00:50:23,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[TREATS],[TREATS],441 AMPHOTERICIN B in HIV infected adolescents with EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS:,n/a,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/13/2015 01:35:39,1635501337,5/13/2015 01:35:12,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],4 6 mg/kg daily.,n/a,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/13/2015 02:10:49,1635520349,5/13/2015 02:10:21,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in,N/A,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/13/2015 02:59:43,1635543312,5/13/2015 02:59:09,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],(a lipid formulation) in HIV infected adolescents with diffuse pulmonary or,no comment,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/13/2015 03:08:51,1635547009,5/13/2015 03:08:34,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],AMPHOTERICIN EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: mg/kg daily.,n/a,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/13/2015 03:20:37,1635552467,5/13/2015 03:18:43,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],lipid formulation),n/a,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440509,5/13/2015 03:25:38,1635554846,5/13/2015 03:25:16,false,neodev,1,32087449,AUS,02,Sydney,203.31.216.214,[PREVENTS],[PREVENTS],adolescents pulmonary,N/A,96,5,-1,140,19,TWrex-cause,803401-FS1,441  AMPHOTERICIN B (a lipid formulation) in HIV infected adolescents with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 4 6 mg/kg daily.,EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,AMPHOTERICIN B
720440510,5/12/2015 18:49:45,1635168343,5/12/2015 18:49:31,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 18:56:17,1635178085,5/12/2015 18:55:36,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 19:08:59,1635197385,5/12/2015 19:08:19,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],occurs,N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 19:21:06,1635226403,5/12/2015 19:19:11,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[OTHER],[OTHER],PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE),N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 19:48:38,1635262949,5/12/2015 19:46:55,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[IS_A],[IS_A],patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE),n/a,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 19:52:56,1635266132,5/12/2015 19:52:38,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE),n/a,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 20:06:53,1635277836,5/12/2015 20:06:28,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[IS_A],[IS_A],PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE),N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 20:22:11,1635289443,5/12/2015 20:20:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 21:07:55,1635318973,5/12/2015 21:07:22,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],(PRIMARY,n/a,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 21:13:41,1635322569,5/12/2015 21:11:10,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",occurs by,N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 21:18:08,1635325289,5/12/2015 21:17:35,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[IS_A],[IS_A],PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE),N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 21:48:17,1635341533,5/12/2015 21:47:27,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE),N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 22:12:04,1635358562,5/12/2015 22:11:19,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[IS_A],[IS_A],PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE),N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 22:23:17,1635367783,5/12/2015 22:22:12,false,clixsense,1,16498372,CAN,ON,Toronto,108.161.124.81,[PART_OF],[PART_OF],PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE),N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440510,5/12/2015 22:35:12,1635378190,5/12/2015 22:34:20,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[IS_A],[IS_A],PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE),N/A,81,102,-1,99,126,TWrex-cause,803247-FS1,Human to human transmission occurs by inhaling droplet nuclei from patients with PULMONARY INFECTION (PRIMARY PNEUMONIC PLAGUE) which is highly contagious.,PULMONARY INFECTION,PRIMARY PNEUMONIC PLAGUE
720440511,5/12/2015 14:39:55,1634933229,5/12/2015 14:39:45,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[LOCATION],[LOCATION],result,kk,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 14:48:03,1634936756,5/12/2015 14:47:46,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],can result from,N/A,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 14:59:02,1634943492,5/12/2015 14:58:32,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],CONJUGATED HYPERBILIRUBINEMIA result from DUBIN JOHNSON SYNDROME,n/a,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 15:02:46,1634946636,5/12/2015 15:01:20,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],can result from,N/A,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 15:25:08,1634973137,5/12/2015 15:24:52,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],can result,N/A,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 15:57:16,1635014120,5/12/2015 15:56:40,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],CONJUGATED HYPERBILIRUBINEMIA can result from DUBIN JOHNSON SYNDROME,N/A,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 17:22:20,1635058858,5/12/2015 17:21:27,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[MANIFESTATION],[MANIFESTATION],due to impaired excretion can result,N/A,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 17:37:48,1635072944,5/12/2015 17:37:17,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[CAUSES],[CAUSES],CONJUGATED HYPERBILIRUBINEMIA can result from DUBIN JOHNSON SYNDROME,N/a,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 17:44:11,1635080048,5/12/2015 17:43:59,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],CONJUGATED HYPERBILIRUBINEMIA impaired excretion result DUBIN JOHNSON SYNDROME,na,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 18:43:54,1635159339,5/12/2015 18:41:48,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 18:47:45,1635165234,5/12/2015 18:46:42,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],result,n/a,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 18:49:03,1635167371,5/12/2015 18:48:40,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],can result from,n/a,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 18:56:36,1635178466,5/12/2015 18:55:42,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],result,N/A,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 19:05:36,1635192232,5/12/2015 19:05:00,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[MANIFESTATION],[MANIFESTATION],can result from,N/A,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440511,5/12/2015 19:25:52,1635236017,5/12/2015 19:23:47,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],can result from,n/a,0,72,1,28,94,TWrex-cause,813049-FS1,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME
720440512,5/12/2015 13:37:55,1634907494,5/12/2015 13:37:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 14:16:15,1634922337,5/12/2015 14:14:59,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 14:35:07,1634930910,5/12/2015 14:34:55,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[LOCATION],[LOCATION],treatment,kjkk,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 14:38:15,1634932496,5/12/2015 14:37:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for treatment,N/A,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 14:38:46,1634932786,5/12/2015 14:38:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],BOTULINUM TOXIN TYPE F for treatment of DYSTONIA:,n/a,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 14:40:38,1634933491,5/12/2015 14:40:07,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 14:43:05,1634934561,5/12/2015 14:42:50,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 14:46:00,1634935753,5/12/2015 14:44:16,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Chen Karp Hallett BOTULINUM TOXIN TYPE F treatment DYSTONIA: long term,na,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 15:16:47,1634962594,5/12/2015 15:16:22,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],BOTULINUM TOXIN TYPE F for treatment of DYSTONIA:,N/A,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 15:34:18,1634984544,5/12/2015 15:34:05,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],BOTULINUM TOXIN TYPE F for treatment of DYSTONIA:,N/A,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 15:45:32,1634998559,5/12/2015 15:45:02,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],BOTULINUM TOXIN TYPE F treatment of DYSTONIA:,N/A,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 15:45:49,1634998876,5/12/2015 15:43:07,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[NONE],[NONE],N/A,"Botulinum toxin type f TREATS dystonia, not the other way around.",68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 16:23:07,1635029030,5/12/2015 16:22:48,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 16:44:57,1635040145,5/12/2015 16:44:40,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440512,5/12/2015 17:30:49,1635065619,5/12/2015 17:29:17,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],BOTULINUM TOXIN TYPE F for treatment of DYSTONIA:,N/a,68,28,-1,75,50,TWrex-cause,800773-FS1,"Chen R, Karp BI, Hallett M. BOTULINUM TOXIN TYPE F for treatment of DYSTONIA: long term experience.",DYSTONIA,BOTULINUM TOXIN TYPE F
720440513,5/12/2015 09:42:51,1634751588,5/12/2015 09:42:03,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(including,Associated with,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 09:48:01,1634755918,5/12/2015 09:46:41,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[IS_A] [MANIFESTATION],"[MANIFESTATION]
[IS_A]","CHEMOTHERAPY INDUCED NEUTROPENIA (incl<span id=""transmark""></span>uding NEUTROPENIA",n/a,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 10:15:11,1634774152,5/12/2015 10:13:38,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF],[PART_OF],(including,N/A,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 10:19:45,1634777713,5/12/2015 10:19:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 10:22:37,1634780283,5/12/2015 10:21:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 10:32:08,1634790794,5/12/2015 10:31:06,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CONTRAINDICATES],[CONTRAINDICATES],exacerbation,none,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 10:52:11,1634812425,5/12/2015 10:51:59,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 10:54:51,1634814711,5/12/2015 10:54:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],(including,n/a,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 11:06:39,1634830468,5/12/2015 11:06:26,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 11:16:49,1634837982,5/12/2015 11:15:34,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],NEUTROPENIA,n/a,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 11:18:12,1634838658,5/12/2015 11:17:51,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],CHEMOTHERAPY,N/A,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 11:31:31,1634846262,5/12/2015 11:30:30,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[IS_A],[IS_A],(including,I did not select 'none'.,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 11:58:29,1634860887,5/12/2015 11:58:11,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 12:06:36,1634864483,5/12/2015 12:05:05,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[IS_A],[IS_A],NEUTROPENIA,N/A,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440513,5/12/2015 12:53:18,1634884874,5/12/2015 12:51:43,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Effects associated with,N/A,71,50,1,81,82,TWrex-cause,812479-FS1,24  Hematologic Effects  Possible exacerbation of CHEMOTHERAPY INDUCED NEUTROPENIA (including fatal sepsis associated with NEUTROPENIA in patients receiving trastuzumab in combination with myelosuppressive chemotherapy.,NEUTROPENIA,CHEMOTHERAPY INDUCED NEUTROPENIA
720440514,5/12/2015 20:20:19,1635288089,5/12/2015 20:19:48,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS:,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/12/2015 20:51:46,1635308536,5/12/2015 20:50:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/12/2015 21:27:03,1635330675,5/12/2015 21:26:52,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/12/2015 21:37:48,1635335905,5/12/2015 21:37:25,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],treatment with,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/12/2015 22:49:39,1635389201,5/12/2015 22:49:10,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS:,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/12/2015 23:08:37,1635404052,5/12/2015 23:07:58,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS:,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/13/2015 00:35:16,1635465366,5/13/2015 00:34:08,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS:,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/13/2015 00:37:39,1635467147,5/13/2015 00:36:40,false,elite,1.0,31848723,USA,"","",155.94.185.254,[SYMPTOM],[SYMPTOM],OMEPRAZOLE REFRACTORY REFLUX ESOPHAGITIS:,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/13/2015 00:53:34,1635478755,5/13/2015 00:53:18,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[TREATS],[TREATS],treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS:,n/a,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/13/2015 02:12:56,1635521260,5/13/2015 02:12:38,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Long term treatment with,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/13/2015 03:02:14,1635544251,5/13/2015 03:01:40,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,no comment,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/13/2015 03:10:14,1635547712,5/13/2015 03:09:57,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS:,n/a,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/13/2015 03:25:14,1635554583,5/13/2015 03:24:25,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],treatment,n/a,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/13/2015 03:27:29,1635555510,5/13/2015 03:26:47,false,neodev,1.0,32087449,AUS,02,Sydney,203.31.216.214,[SYMPTOM],[SYMPTOM],REFRACTORY ESOPHAGITIS:,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440514,5/13/2015 03:33:34,1635558197,5/13/2015 03:33:21,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS:,N/A,92,77,-1,120,87,TWrex-cause,800538-FS1,"Klinkenberg Knol EC, Festen HPM, Jansen JBMJ et al. Long term treatment with OMEPRAZOLE for REFRACTORY REFLUX ESOPHAGITIS: efficacy and safety.",REFRACTORY REFLUX ESOPHAGITIS,OMEPRAZOLE
720440515,5/12/2015 19:30:17,1635243096,5/12/2015 19:29:37,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[OTHER],[OTHER],occurs in,N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 19:56:19,1635269590,5/12/2015 19:55:58,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 19:58:40,1635271653,5/12/2015 19:57:58,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[IS_A],[IS_A],occurs in approximately 2% of patients,n/a,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 20:11:36,1635281683,5/12/2015 20:11:00,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PAPILLARY THYROID CANCER occurs in patients with FAMILIAL ADENOMATOUS POLYPOSIS,N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 20:34:11,1635297438,5/12/2015 20:32:46,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[IS_A],[IS_A],"PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 21:16:56,1635324654,5/12/2015 21:14:17,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 21:26:23,1635330349,5/12/2015 21:25:56,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",occurs in patients with,N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 22:35:18,1635378266,5/12/2015 22:34:42,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],PAPILLARY THYROID CANCER occurs in patients with FAMILIAL ADENOMATOUS POLYPOSIS,N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 22:38:37,1635380771,5/12/2015 22:38:18,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS,N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 22:40:44,1635382346,5/12/2015 22:39:56,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",PAPILLARY THYROID CANCER occurs in patients with FAMILIAL ADENOMATOUS POLYPOSIS,N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/12/2015 23:46:33,1635432562,5/12/2015 23:45:00,false,neodev,1.0,31294288,GBR,V2,Glasgow,92.0.224.52,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",occurs in approximately 2% of patients with,N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/13/2015 00:02:10,1635443527,5/13/2015 00:00:52,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[MANIFESTATION],[MANIFESTATION],PAPILLARY THYROID CANCER occurs in patients FAMILIAL ADENOMATOUS POLYPOSIS female who manifest,N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/13/2015 00:06:12,1635445944,5/13/2015 00:04:52,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PAPILLARY THYROID occurs approximately 2% patients with FAMILIAL ADENOMATOUS POLYPOSIS,n/a,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/13/2015 00:31:39,1635462740,5/13/2015 00:31:07,false,elite,1.0,31848723,USA,"","",155.94.185.254,[SYMPTOM],[SYMPTOM],PAPILLARY THYROID CANCER FAMILIAL ADENOMATOUS POLYPOSIS,N/A,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440515,5/13/2015 01:27:16,1635496406,5/13/2015 01:26:58,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs in approximately,n/a,2,71,1,25,101,TWrex-cause,813608-FS1,"‚Ä¢ PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS
720440516,5/12/2015 20:18:37,1635286911,5/12/2015 20:18:13,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[IS_A],[IS_A],"CHRONIC INFECTIONS (e.g., LYME DISEASE",N/A,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/12/2015 20:48:01,1635306391,5/12/2015 20:46:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12 deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",N/A,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/12/2015 21:24:50,1635329410,5/12/2015 21:23:57,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],"(e.g.,",n/a,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/12/2015 21:34:16,1635334125,5/12/2015 21:33:46,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[IS_A],[IS_A],"(e.g.,",N/A,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/12/2015 22:47:54,1635387921,5/12/2015 22:46:26,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",CHRONIC INFECTIONS LYME DISEASE,N/A,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/12/2015 22:48:24,1635388265,5/12/2015 22:47:33,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"CHRONIC INFECTIONS (e.g., LYME DISEASE",N/A,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/13/2015 00:24:57,1635458006,5/13/2015 00:23:12,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A],[IS_A],include CHRONIC INFECTIONS LYME DISEASE,N/A,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/13/2015 00:35:52,1635465719,5/13/2015 00:35:35,false,elite,1.0,31848723,USA,"","",155.94.185.254,[SIDE_EFFECT],[SIDE_EFFECT],CHRONIC INFECTIONS LYME DISEASE,N/A,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/13/2015 00:51:55,1635477525,5/13/2015 00:51:22,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[IS_A],[IS_A],"CHRONIC INFECTIONS (e.g., LYME DISEASE",n/a,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/13/2015 01:36:23,1635501814,5/13/2015 01:35:40,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],considerations include,n/a,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/13/2015 02:11:33,1635520663,5/13/2015 02:10:51,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH] [PREVENTS],"[PREVENTS]
[ASSOCIATED_WITH]",Frequent diagnostic considerations include,N/A,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/13/2015 03:00:42,1635543591,5/13/2015 02:59:44,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"(e.g., syphilis,",no comment,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/13/2015 03:09:11,1635547147,5/13/2015 03:08:52,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",CHRONIC INFECTIONS LYME DISEASE,n/a,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/13/2015 03:22:14,1635553279,5/13/2015 03:20:37,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"CHRONIC INFECTIONS (e.g., LYME DISEASE",n/a,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440516,5/13/2015 03:25:58,1635554958,5/13/2015 03:25:41,false,neodev,1.0,32087449,AUS,02,Sydney,203.31.216.214,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"lesions, virus",N/A,145,181,-1,162,193,TWrex-cause,803093-FS1,"Frequent diagnostic considerations include structural lesions, inherited demyelinating or degenerative diseases, vasculitides, vascular disease, CHRONIC INFECTIONS (e.g., syphilis, LYME DISEASE and human T cell lymphotropic virus type I), vitamin B 12  deficiency, rheumatologic diseases, Behcet disease, neuromyelitis optica (NMO), and neurosarcoidosis.",CHRONIC INFECTIONS,LYME DISEASE
720440517,5/12/2015 13:37:41,1634907416,5/12/2015 13:37:07,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],potential vehicle for transmission transmitting,n/a,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 14:14:58,1634921793,5/12/2015 14:14:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PART_OF],[PART_OF],including the causative agents,N/A,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 14:34:48,1634930767,5/12/2015 14:34:37,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[CAUSES],[CAUSES],Plasma,',243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 14:37:04,1634931977,5/12/2015 14:35:41,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],including,N/A,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 14:38:09,1634932422,5/12/2015 14:37:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],HUMAN VIRUSES including VIRAL HEPATITIS,n/a,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 14:40:02,1634933256,5/12/2015 14:38:35,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PART_OF],[PART_OF],including,N/A,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 14:42:49,1634934470,5/12/2015 14:41:57,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[CONTRAINDICATES],[CONTRAINDICATES],derived,N/A,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 14:44:16,1634935072,5/12/2015 14:43:47,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"116 Warnings/Precautions Warnings Risk Transmissible Agents Plasma derived Preparations HBIG prepared pooled human plasma, potential vehicle transmission HUMAN VIRUSES including causative agents VIRAL HEPATITIS HIV infection, may carry risk transmitting causative agent Creutzfeldt Jakob disease variant",na,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 15:16:21,1634962026,5/12/2015 15:15:57,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],HUMAN VIRUSES including VIRAL HEPATITIS,N/A,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 15:34:04,1634984248,5/12/2015 15:33:35,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[PART_OF],[PART_OF],HUMAN VIRUSES including VIRAL HEPATITIS,N/A,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 15:42:44,1634994925,5/12/2015 15:42:18,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],causative,n/a,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 15:43:06,1634995492,5/12/2015 15:41:28,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[CAUSES],[CAUSES],causative agents of,N/A,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 15:45:01,1634997921,5/12/2015 15:43:58,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],HUMAN VIRUSES causative agents of VIRAL HEPATITIS,N/A,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 16:22:46,1635028861,5/12/2015 16:21:28,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF],[PART_OF],including,N/A,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440517,5/12/2015 17:26:12,1635061721,5/12/2015 17:25:36,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[IS_A],[IS_A],including the,N/a,243,195,1,257,208,TWrex-cause,810183-FS1,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
720440518,5/12/2015 09:53:12,1634759524,5/12/2015 09:52:38,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],causes,Caused by,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 10:04:35,1634767406,5/12/2015 10:04:06,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[CAUSES],[CAUSES],"EPSTEIN BARR VIRUS EBV causes infec<span id=""transmark""></span>tious MONONUCLEOSIS",n/a,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 10:32:45,1634791442,5/12/2015 10:32:30,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],causes infectious,N/A,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 10:34:24,1634793188,5/12/2015 10:33:16,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes,N/A,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 10:41:11,1634802108,5/12/2015 10:40:53,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],causes,n/a,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 10:43:45,1634805339,5/12/2015 10:43:18,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],causes,none,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 11:04:22,1634827186,5/12/2015 11:03:58,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],causes,n/a,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 11:10:45,1634834120,5/12/2015 11:10:34,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],causes,n/a,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 11:17:04,1634838097,5/12/2015 11:16:53,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[CAUSES],[CAUSES],causes,N/A,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 11:24:47,1634841729,5/12/2015 11:23:51,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],infectious MONONUCLEOSIS,N/A,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 11:34:42,1634848152,5/12/2015 11:34:04,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],causes,n/a,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 11:41:58,1634852345,5/12/2015 11:41:34,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[CAUSES],[CAUSES],causes,I did not select 'none'.,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 12:39:06,1634878920,5/12/2015 12:38:42,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[CAUSES],[CAUSES],causes,N/A,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 13:19:04,1634895337,5/12/2015 13:18:45,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],causes,N/A,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440518,5/12/2015 13:32:29,1634905157,5/12/2015 13:32:14,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],causes,n/a,46,4,1,58,27,TWrex-cause,810460-FS1,41  EPSTEIN BARR VIRUS  EBV causes infectious MONONUCLEOSIS and has been implicated as a cause of nasopharyngeal carcinoma and Burkitt lymphoma.,MONONUCLEOSIS,EPSTEIN BARR VIRUS  EBV
720440519,5/12/2015 09:40:05,1634749321,5/12/2015 09:39:35,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PREVENTS],[PREVENTS],treatment,Treatment of,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 09:40:12,1634749360,5/12/2015 09:38:19,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[NONE],[NONE],n/a,there is no direct relation between neomycin and pse,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 09:41:26,1634750394,5/12/2015 09:40:52,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],administered to,n/a,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 09:42:01,1634750815,5/12/2015 09:39:22,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],administered,N/A,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 10:09:43,1634770673,5/12/2015 10:08:32,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],administered to,N/A,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 10:17:07,1634775539,5/12/2015 10:16:40,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy,n/a,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 10:20:38,1634778584,5/12/2015 10:20:13,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],administered with,N/A,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 10:29:28,1634787849,5/12/2015 10:28:56,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 10:51:08,1634811690,5/12/2015 10:50:54,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],when administered with,N/A,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 10:52:15,1634812571,5/12/2015 10:51:27,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 11:05:40,1634829018,5/12/2015 11:05:14,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],effective,n/a,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 11:16:32,1634837822,5/12/2015 11:15:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],NEOMYCIN,N/A,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 11:27:13,1634843272,5/12/2015 11:25:42,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[MANIFESTATION],[MANIFESTATION],appears to remain active,Did not select 'none'.,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 11:56:04,1634859807,5/12/2015 11:55:38,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],with,n/a,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440519,5/12/2015 12:01:31,1634862217,5/12/2015 12:00:45,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],therapy,N/A,97,71,-1,99,79,TWrex-cause,800540-FS1,"1   However, lactulose appears to remain active when administered with NEOMYCIN to patients with PSE and some reports suggest that such concomitant therapy may be more effective than either drug alone in the treatment of PSE.",PSE,NEOMYCIN
720440520,5/12/2015 13:31:02,1634904014,5/12/2015 13:29:22,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],could have,N/A,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 13:35:18,1634906404,5/12/2015 13:34:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],could have,n/a,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 14:09:53,1634919994,5/12/2015 14:09:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],could have,N/A,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 14:25:13,1634926396,5/12/2015 14:24:58,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],POSTPARTUM THYROTOXICOSIS could have GRAVES DISEASE,n/a,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 14:26:30,1634926923,5/12/2015 14:25:10,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],could have,N/A,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 14:32:03,1634929367,5/12/2015 14:31:29,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],could have,N/A,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 14:32:39,1634929640,5/12/2015 14:32:12,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[MANIFESTATION],[MANIFESTATION],"thyroiditis,",jkk,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 14:32:44,1634929663,5/12/2015 14:32:07,false,prodege,1.0,2145087,USA,NY,New York,107.107.63.230,[MANIFESTATION],[MANIFESTATION],could have,N/a,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 14:33:47,1634930255,5/12/2015 14:32:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with POSTPARTUM THYROTOXICOSIS could have GRAVES DISEASE,n/a,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 14:39:46,1634933182,5/12/2015 14:39:20,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 14:41:16,1634933821,5/12/2015 14:40:50,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"woman POSTPARTUM THYROTOXICOSIS painless (postpartum) thyroiditis, GRAVES DISEASE factitious thyrotoxicosis‚Äîeach which would treated quite differently.",na,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 15:12:10,1634956651,5/12/2015 15:11:23,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],POSTPARTUM THYROTOXICOSIS GRAVES DISEASE,N/A,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 15:27:24,1634975796,5/12/2015 15:24:42,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[MANIFESTATION],[MANIFESTATION],POSTPARTUM THYROTOXICOSIS could have GRAVES DISEASE,I didn't select none,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 15:29:24,1634978326,5/12/2015 15:28:56,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],a woman with POSTPARTUM THYROTOXICOSIS could have GRAVES DISEASE,N/A,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440520,5/12/2015 15:29:38,1634978587,5/12/2015 15:29:06,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],a woman with could have,n/a,98,26,1,111,51,TWrex-cause,814787-FS1,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis‚Äîeach of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS
720440521,5/12/2015 09:54:40,1634760562,5/12/2015 09:54:13,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],lead,Caused by,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 10:07:33,1634769195,5/12/2015 10:06:33,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[CAUSES],[CAUSES],"HEMOCHROMATOSIS lead to atria<span id=""transmark""></span>l tachyARRHYTHMIAS,",n/a,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 10:34:28,1634793253,5/12/2015 10:34:08,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],may lead,N/A,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 10:37:32,1634797219,5/12/2015 10:35:38,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],may lead to,N/A,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 10:45:55,1634808193,5/12/2015 10:44:58,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],may lead to,none,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 10:50:42,1634811390,5/12/2015 10:50:15,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],may lead to,n/a,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 11:06:16,1634829844,5/12/2015 11:05:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],may lead to,n/a,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 11:17:52,1634838515,5/12/2015 11:17:32,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[CAUSES],[CAUSES],may lead to,N/A,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 11:27:48,1634843561,5/12/2015 11:25:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],HEMOCHROMATOSIS,N/A,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 11:36:11,1634848959,5/12/2015 11:35:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],may lead to,n/a,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 11:44:06,1634853629,5/12/2015 11:43:36,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[CAUSES],[CAUSES],may lead to,I did not select 'none'.,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 12:40:53,1634879904,5/12/2015 12:39:58,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[MANIFESTATION],[MANIFESTATION],may lead to,N/A,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 13:22:39,1634897129,5/12/2015 13:21:17,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],may lead to,N/A,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 13:33:14,1634905551,5/12/2015 13:32:58,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],lead to,n/a,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440521,5/12/2015 13:55:21,1634914600,5/12/2015 13:54:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],may lead to,N/A,158,13,1,168,28,TWrex-cause,813611-FS1,"Rationale: ‚Ä¢ HEMOCHROMATOSIS may lead to dilated or restrictive cardiomyopathy, cardiac arrhythmias, or both, and the most common arrhythmias are atrial tachyARRHYTHMIAS, followed by ventricular premature beats and, rarely, ventricular tachycardia.",ARRHYTHMIAS,HEMOCHROMATOSIS
720440522,5/12/2015 19:13:52,1635207465,5/12/2015 19:13:21,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],caused,N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 19:29:35,1635242069,5/12/2015 19:29:00,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[CAUSES],[CAUSES],caused by,N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 19:55:56,1635269159,5/12/2015 19:55:28,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],most often caused,n/a,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 19:57:57,1635271051,5/12/2015 19:57:26,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],may be caused by,n/a,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 20:10:59,1635281274,5/12/2015 20:10:24,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CAUSES],[CAUSES],BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS caused by BACTERIA[1],N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 20:32:45,1635296542,5/12/2015 20:31:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Causes [edit] Infectious parotitis Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1] Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 21:14:16,1635322964,5/12/2015 21:13:54,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],any,n/a,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 21:25:54,1635330056,5/12/2015 21:25:33,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],caused by,N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 22:34:40,1635377788,5/12/2015 22:33:34,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Acute bacterial parotitis: most often caused by BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS may be caused by BACTERIA[1],N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 22:38:16,1635380552,5/12/2015 22:37:55,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by BACTERIA[1],N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 22:39:55,1635381687,5/12/2015 22:39:23,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CAUSES],[CAUSES],BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS may be caused by BACTERIA[1],N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 23:44:33,1635430999,5/12/2015 23:43:36,false,neodev,1.0,31294288,GBR,V2,Glasgow,92.0.224.52,[CAUSES] [MANIFESTATION] [ASSOCIATED_WITH],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",may be caused by any commensal,N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 23:57:44,1635440470,5/12/2015 23:56:28,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],Causes STAPHYLOCOCCUS AUREUS BACTERIA[1],N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/12/2015 23:59:12,1635441475,5/12/2015 23:56:40,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]",caused by BACTERIAL INFECTION OF STAPHYLOCOCCUS but may be caused by commensal BACTERIA[1],n/a,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440522,5/13/2015 00:31:05,1635462397,5/13/2015 00:30:34,false,elite,1.0,31848723,USA,"","",155.94.185.254,[CAUSES],[CAUSES],BACTERIAL INFECTION STAPHYLOCOCCUS AUREUS BACTERIA[1],N/A,89,169,1,132,177,TWrex-cause,810102-FS1,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA
720440523,5/12/2015 13:38:10,1634907666,5/12/2015 13:37:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],require supplemental,n/a,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 14:16:40,1634922481,5/12/2015 14:16:16,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],may require,N/A,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 14:35:25,1634931036,5/12/2015 14:35:11,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[CAUSES],[CAUSES],IRON,klkll,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 14:39:44,1634933168,5/12/2015 14:38:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],IRON DEFICIENCY ANEMIA may require IRON,n/a,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 14:40:01,1634933245,5/12/2015 14:38:20,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],may require,N/A,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 14:43:37,1634934805,5/12/2015 14:43:05,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],may require,N/A,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 14:46:21,1634935917,5/12/2015 14:46:01,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],IRON DEFICIENCY ANEMIA require IRON,na,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 15:17:13,1634963173,5/12/2015 15:16:49,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",IRON DEFICIENCY ANEMIA may require supplemental IRON,N/A,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 15:35:02,1634985476,5/12/2015 15:34:19,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],IRON DEFICIENCY ANEMIA may require supplemental IRON,N/A,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 15:46:03,1634999212,5/12/2015 15:45:34,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],IRON DEFICIENCY ANEMIA may require supplemental IRON,N/A,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 15:48:11,1635002094,5/12/2015 15:45:49,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[NONE],[NONE],N/A,Iron TREATS Iron Deficiency Anemia not the other way around.,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 16:23:57,1635029448,5/12/2015 16:23:08,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],may require supplemental,N/A,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 16:45:30,1635040474,5/12/2015 16:44:59,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],supplemental,n/a,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 17:04:40,1635050575,5/12/2015 17:04:09,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],require supplemental,N/A,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440523,5/12/2015 17:26:37,1635062044,5/12/2015 17:26:13,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],require supplemental,N/a,0,0,-1,21,4,TWrex-cause,804747-FS1,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON
720440524,5/12/2015 19:13:20,1635206222,5/12/2015 19:12:25,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PART_OF],[PART_OF],include,N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 19:28:58,1635240961,5/12/2015 19:27:41,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[OTHER],[OTHER],include,N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 19:55:27,1635268678,5/12/2015 19:55:00,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],and,n/a,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 19:57:25,1635270576,5/12/2015 19:55:37,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ASSOCIATED WITH,n/a,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 20:10:23,1635280667,5/12/2015 20:09:45,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SYSTEM ATROPHY (MSA) and DEMENTIA ASSOCIATED WITH PARKINSONISM,N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 20:31:06,1635295514,5/12/2015 20:29:40,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[SIDE_EFFECT]","Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 21:10:26,1635320609,5/12/2015 21:09:53,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],syndromes,n/a,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 21:25:31,1635329732,5/12/2015 21:24:53,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[MANIFESTATION] [ASSOCIATED_WITH] [NONE],"[MANIFESTATION]
[ASSOCIATED_WITH]
[NONE]",N/A,Both terms associate with the same syndrome.,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 22:21:23,1635366098,5/12/2015 22:18:25,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Other parkinsonian syndromes include SYSTEM ATROPHY and DEMENTIA ASSOCIATED,N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 22:37:54,1635380255,5/12/2015 22:37:24,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Other parkinsonian syndromes include multiple SYSTEM ATROPHY vascular parkinsonism, and DEMENTIA ASSOCIATED WITH PARKINSONISM",N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 22:39:22,1635381296,5/12/2015 22:38:33,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",parkinsonian syndromes include SYSTEM ATROPHY DEMENTIA ASSOCIATED WITH PARKINSONISM,N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 23:35:02,1635424001,5/12/2015 23:34:20,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Other parkinsonian syndromes include SYSTEM ATROPHY (MSA) and DEMENTIA ASSOCIATED WITH PARKINSONISM,n/a,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 23:43:25,1635430144,5/12/2015 23:42:16,false,neodev,1.0,31294288,GBR,V2,Glasgow,92.0.224.52,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]","(NPH), drug induced parkinsonism (DIP),",N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/12/2015 23:56:28,1635439616,5/12/2015 23:54:24,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],syndromes include SYSTEM ATROPHY (MSA) DEMENTIA ASSOCIATED WITH PARKINSONISM,N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440524,5/13/2015 00:30:32,1635461980,5/13/2015 00:29:52,false,elite,1.0,31848723,USA,"","",155.94.185.254,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SYSTEM DEMENTIA ASSOCIATED WITH PARKINSONISM,N/A,231,113,1,267,133,TWrex-cause,812801-FS1,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA)
720440525,5/12/2015 09:59:01,1634764102,5/12/2015 09:58:16,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],reduce,Treat with,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 10:15:15,1634774179,5/12/2015 10:12:54,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[OTHER],[OTHER],"DROTRECOGIN ALFA reduce mortality in SEP<span id=""transmark""></span>SIS",n/a,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 10:37:35,1634797328,5/12/2015 10:36:59,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],has been shown,N/A,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 10:43:56,1634805517,5/12/2015 10:43:09,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],significantly reduce,N/A,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 10:49:18,1634810327,5/12/2015 10:48:41,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],significantly reduce mortality,none,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 10:53:27,1634813365,5/12/2015 10:52:56,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],significantly reduce mortality,n/a,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 11:09:15,1634833129,5/12/2015 11:08:45,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],has been shown to significantly reduce mortality,n/a,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 11:19:47,1634839394,5/12/2015 11:19:27,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],significantly reduce mortality in patients with,N/A,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 11:33:41,1634847714,5/12/2015 11:33:21,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],placebo.,N/A,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 11:39:39,1634850859,5/12/2015 11:39:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],reduce mortality,n/a,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 11:48:46,1634856175,5/12/2015 11:48:07,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[PREVENTS],[PREVENTS],has been shown to significantly reduce,I did not select 'none'.,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 12:43:47,1634881102,5/12/2015 12:42:52,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],reduce mortality,N/A,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 13:29:21,1634902373,5/12/2015 13:28:39,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],reduce mortality,N/A,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 13:34:56,1634906312,5/12/2015 13:34:37,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],reduce mortality,n/a,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440525,5/12/2015 14:05:30,1634918380,5/12/2015 14:05:02,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],reduce mortality,N/A,159,56,-1,164,72,TWrex-cause,800824-FS1,"44 , 45  Recombinant human activated protein C (APC, or DROTRECOGIN ALFA [activated]) has been shown to significantly reduce mortality in patients with severe SEPSIS (mortality was 24.7% in patients given APC versus 30.8% in patients given placebo.",SEPSIS,DROTRECOGIN ALFA
720440526,5/12/2015 16:05:40,1635020131,5/12/2015 16:05:05,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PREVENTS],[PREVENTS],ASPIRIN primary prevention of MYOCARDIAL INFARCTION,N/A,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 17:47:15,1635083331,5/12/2015 17:46:41,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ASPIRIN primary prevention of MYOCARDIAL INFARCTION,N/a,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 18:48:36,1635166538,5/12/2015 18:48:20,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 18:54:38,1635175444,5/12/2015 18:53:47,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",prevention of,n/a,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 19:06:45,1635193890,5/12/2015 19:06:26,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],prevention,N/A,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 19:17:23,1635216819,5/12/2015 19:17:02,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[PREVENTS],[PREVENTS],primary prevention,N/A,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 19:43:51,1635259494,5/12/2015 19:43:33,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],primary prevention,n/a,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 19:51:27,1635264996,5/12/2015 19:51:06,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [PREVENTS],"[PREVENTS]
[ASSOCIATED_WITH]",primary prevention,n/a,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 20:04:12,1635275924,5/12/2015 20:03:50,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[PREVENTS],[PREVENTS],ASPIRIN primary prevention of MYOCARDIAL INFARCTION,N/A,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 20:17:39,1635286218,5/12/2015 20:16:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,N/A,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 20:48:54,1635306930,5/12/2015 20:48:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],in primary prevention of,N/A,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 21:06:01,1635317701,5/12/2015 21:05:49,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],prevention,n/a,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 21:07:43,1635318867,5/12/2015 21:07:13,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",primary prevention,N/A,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 21:15:05,1635323493,5/12/2015 21:14:33,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PREVENTS],[PREVENTS],prevention of,N/A,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440526,5/12/2015 21:47:25,1635341145,5/12/2015 21:46:11,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],ASPIRIN primary prevention of MYOCARDIAL INFARCTION,N/A,55,22,-1,75,29,TWrex-cause,803816-FS1,Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,MYOCARDIAL INFARCTION,ASPIRIN
720440527,5/12/2015 09:45:54,1634754159,5/12/2015 09:44:55,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],differentiated,Associated with,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 09:52:57,1634759401,5/12/2015 09:51:45,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[OTHER],[OTHER],"CMV MONONUCLEOSIS can be differentiated from (EPSTEIN BARR VIR<span id=""transmark""></span>US)",n/a,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 10:20:25,1634778412,5/12/2015 10:19:40,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],differentiated from,N/A,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 10:26:07,1634783773,5/12/2015 10:25:50,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],differentiated,N/A,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 10:35:12,1634794172,5/12/2015 10:34:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[OTHER],[OTHER],differentiated,differs from,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 10:35:47,1634794889,5/12/2015 10:35:00,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[OTHER],[OTHER],differentiated from,none,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 10:58:20,1634818621,5/12/2015 10:57:33,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[OTHER],[OTHER],can be differentiated from,n/a,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 11:07:37,1634831832,5/12/2015 11:07:20,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],differentiated,n/a,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 11:11:02,1634834273,5/12/2015 11:10:45,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[OTHER],[OTHER],differentiated from infectious,N/A,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 11:19:05,1634839007,5/12/2015 11:18:29,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[NONE],[NONE],N/A,different illnesses,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 11:19:32,1634839257,5/12/2015 11:19:18,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],(EPSTEIN,N/A,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 11:35:56,1634848807,5/12/2015 11:34:32,false,clixsense,1,29594612,NLD,11,Rotterdam,82.156.132.195,[OTHER],[OTHER],can sometimes be differentiated from,Two similar deseases that can be differentiated from each other.,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 12:03:41,1634863172,5/12/2015 12:01:55,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],differentiated,n/a,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 12:09:54,1634865912,5/12/2015 12:09:21,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.56,[OTHER],[OTHER],mononucleosis,N/A,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440527,5/12/2015 13:03:47,1634888797,5/12/2015 13:02:43,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],differentiated,N/A,0,67,1,16,85,TWrex-cause,815081-FS1,"CMV MONONUCLEOSIS can sometimes be differentiated from infectious (EPSTEIN BARR VIRUS) mononucleosis by the absence of pharyngitis, a negative heterophil antibody test, and serology.",CMV MONONUCLEOSIS,EPSTEIN BARR VIRUS
720440528,5/12/2015 09:49:11,1634756846,5/12/2015 09:48:41,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,Associated with,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 09:58:11,1634763250,5/12/2015 09:57:08,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[MANIFESTATION],[MANIFESTATION],"HEPATOMEGALY in AMYLOIDOSIS OF THE LI<span id=""transmark""></span>VER",na/,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 10:27:23,1634785256,5/12/2015 10:26:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],in a patient with,N/A,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 10:29:54,1634788261,5/12/2015 10:29:25,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[MANIFESTATION],[MANIFESTATION],showing marked,N/A,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 10:37:56,1634797745,5/12/2015 10:37:32,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],showing marked HEPATOMEGALY,n/a,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 10:39:40,1634800144,5/12/2015 10:38:27,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],showing marked,none,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 11:01:36,1634822992,5/12/2015 11:01:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],in a patient with,n/a,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 11:09:15,1634833091,5/12/2015 11:08:57,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],showing,n/a,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 11:14:04,1634836389,5/12/2015 11:13:37,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",showing marked HEPATOMEGALY in a patient with,N/A,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 11:21:28,1634840250,5/12/2015 11:21:16,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],LIVER spleen.,N/A,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 11:28:01,1634843689,5/12/2015 11:27:37,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],showing marked,n/a,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 11:38:51,1634850406,5/12/2015 11:38:16,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[MANIFESTATION],[MANIFESTATION],showing marked,I did not select 'none'.,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 12:13:07,1634867310,5/12/2015 12:12:26,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[MANIFESTATION],[MANIFESTATION],showing,N/A,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 13:14:21,1634893357,5/12/2015 13:11:53,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],showing,N/A,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440528,5/12/2015 13:30:45,1634903714,5/12/2015 13:30:31,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],showing,n/a,68,99,1,79,126,TWrex-cause,814273-FS1,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER
720440529,5/12/2015 14:18:54,1634923477,5/12/2015 14:18:36,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment with,N/A,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 14:36:23,1634931567,5/12/2015 14:36:09,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[LOCATION],[LOCATION],PRAZIQUANTEL,kjkk,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 14:44:43,1634935251,5/12/2015 14:44:30,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 14:45:05,1634935385,5/12/2015 14:43:38,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 14:47:43,1634936623,5/12/2015 14:45:06,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],alCLONORCHIASIS: treatment with PRAZIQUANTEL,n/a,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 14:48:34,1634936963,5/12/2015 14:48:05,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[TREATS],[TREATS],alCLONORCHIASIS: treatment PRAZIQUANTEL 50 cases.,na,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 15:18:28,1634965036,5/12/2015 15:18:07,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment with,N/A,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 15:48:25,1635002424,5/12/2015 15:47:48,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],alCLONORCHIASIS: treatment with PRAZIQUANTEL,N/A,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 15:52:44,1635007985,5/12/2015 15:52:26,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[TREATS],[TREATS],treatment with,n/a,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 16:47:17,1635041510,5/12/2015 16:46:58,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 17:07:47,1635052101,5/12/2015 17:06:45,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment with,N/A,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 17:28:36,1635063614,5/12/2015 17:28:19,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],alCLONORCHIASIS: treatment with PRAZIQUANTEL,N/a,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 18:19:24,1635123306,5/12/2015 18:18:56,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 18:37:52,1635149268,5/12/2015 18:37:32,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440529,5/12/2015 18:43:11,1635158046,5/12/2015 18:42:53,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment with,n/a,40,70,-1,52,82,TWrex-cause,803386-FS1,"Qi Hong K, Yun Tian Z, Shu Zhoug L et alCLONORCHIASIS: treatment with PRAZIQUANTEL in 50 cases.",CLONORCHIASIS,PRAZIQUANTEL
720440530,5/12/2015 09:47:05,1634755067,5/12/2015 09:46:37,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[IS_A],[IS_A],with,Is a,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 09:55:18,1634760928,5/12/2015 09:54:17,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[MANIFESTATION] [PART_OF] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]","IMMOTILE CILIA SYNDROME include BRONCH<span id=""transmark""></span>IECTASIS",n/a,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 10:22:43,1634780385,5/12/2015 10:21:28,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF],[PART_OF],to include all with,N/A,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 10:27:37,1634785534,5/12/2015 10:26:44,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],was coined to,N/A,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 10:36:36,1634796035,5/12/2015 10:35:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],include all patients with,n/a,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 10:37:19,1634796953,5/12/2015 10:36:19,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],include,none,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 11:00:02,1634820914,5/12/2015 10:59:30,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PART_OF],[PART_OF],coined to include,n/a,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 11:08:09,1634832318,5/12/2015 11:07:53,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 11:11:55,1634834885,5/12/2015 11:11:30,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[PART_OF],[PART_OF],to include,N/A,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 11:20:40,1634839850,5/12/2015 11:20:15,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BRONCHIECTASIS,N/A,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 11:26:33,1634842761,5/12/2015 11:24:45,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],coined to include,n/a,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 11:37:16,1634849600,5/12/2015 11:36:33,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[MANIFESTATION],[MANIFESTATION],the term was coined to include,I did not select 'none'.,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 12:10:51,1634866390,5/12/2015 12:10:22,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[SYMPTOM],[SYMPTOM],with,N/A,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 13:08:18,1634890659,5/12/2015 13:05:51,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PART_OF],[PART_OF],include,N/A,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440530,5/12/2015 13:29:52,1634902905,5/12/2015 13:29:26,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,n/a,101,15,1,114,38,TWrex-cause,812890-FS1,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME
720440531,5/12/2015 14:28:15,1634927691,5/12/2015 14:27:44,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 14:38:06,1634932407,5/12/2015 14:37:53,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[TREATS],[TREATS],GONORRHEA,;'';',91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 14:46:38,1634936055,5/12/2015 14:46:20,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 14:54:55,1634940368,5/12/2015 14:53:53,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],GONORRHEA caused by NEISSERIA GONORRHOEAE,n/a,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 14:55:11,1634940532,5/12/2015 14:53:28,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 15:23:00,1634970450,5/12/2015 15:22:37,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],caused by,N/A,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 15:54:01,1635009827,5/12/2015 15:53:30,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],GONORRHEA caused by NEISSERIA GONORRHOEAE,N/A,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 17:15:35,1635055499,5/12/2015 17:14:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by susceptible,N/A,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 17:34:43,1635069656,5/12/2015 17:33:41,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[CAUSES],[CAUSES],GONORRHEA caused by susceptible NEISSERIA GONORRHOEAE,N/a,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 17:39:27,1635075008,5/12/2015 17:39:10,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Gonorrhea Associated Infections Alternative treatment GONORRHEA urethritis) caused susceptible NEISSERIA GONORRHOEAE,na,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 18:35:14,1635145651,5/12/2015 18:34:44,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 18:39:55,1635152690,5/12/2015 18:39:42,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 18:46:30,1635163150,5/12/2015 18:46:06,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment of,n/a,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 18:52:21,1635172312,5/12/2015 18:51:49,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440531,5/12/2015 19:02:39,1635187979,5/12/2015 19:02:11,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[CAUSES],[CAUSES],caused by,N/A,91,147,1,99,168,TWrex-cause,811285-FS1,"c ,   116  Gonorrhea and Associated Infections  Alternative for treatment of uncomplicated GONORRHEA (including urethritis) caused by susceptible  NEISSERIA GONORRHOEAE",GONORRHEA,NEISSERIA GONORRHOEAE
720440532,5/12/2015 09:53:35,1634759764,5/12/2015 09:53:13,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 10:04:57,1634767652,5/12/2015 10:04:37,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],"alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE <span id=""transmark""></span>DISORDER:",n/a,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 10:33:47,1634792403,5/12/2015 10:32:46,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 10:35:01,1634793975,5/12/2015 10:34:28,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 10:41:29,1634802486,5/12/2015 10:41:12,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 10:44:17,1634805980,5/12/2015 10:43:47,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 11:04:55,1634827821,5/12/2015 11:04:23,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment,n/a,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 11:10:56,1634834252,5/12/2015 11:10:47,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 11:17:16,1634838190,5/12/2015 11:17:05,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],treatment,N/A,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 11:25:16,1634841960,5/12/2015 11:24:48,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[MANIFESTATION],[MANIFESTATION],alCLOMIPRAMINE,N/A,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 11:35:11,1634848430,5/12/2015 11:34:43,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,n/a,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 11:43:06,1634853037,5/12/2015 11:41:59,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],treatment of,I did not select 'none'.,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 12:39:26,1634879073,5/12/2015 12:39:07,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],treatment,N/A,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 13:19:23,1634895544,5/12/2015 13:19:05,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440532,5/12/2015 13:32:42,1634905276,5/12/2015 13:32:30,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,64,38,-1,102,50,TWrex-cause,800551-FS1,"Flament MF, Rapoport JL, Berg CJ et alCLOMIPRAMINE treatment of CHILDHOOD OBSESSIVE COMPULSIVE DISORDER: a double blind controlled study.",CHILDHOOD OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
720440533,5/12/2015 14:40:20,1634933378,5/12/2015 14:40:07,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[CAUSES],[CAUSES],AMPHOTERICIN,jkkj,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 14:48:29,1634936953,5/12/2015 14:48:04,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],Initial regimen,N/A,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 15:00:09,1634944425,5/12/2015 14:59:06,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],BLASTOMYCOSIS: regimen of IV AMPHOTERICIN B,n/a,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 15:03:55,1634947670,5/12/2015 15:02:47,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],Initial regimen until abnormalities resolve.,N/A,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 15:25:38,1634973712,5/12/2015 15:25:09,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],Initial regimen of,N/A,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 15:58:01,1635015152,5/12/2015 15:57:21,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],BLASTOMYCOSIS: regimen of IV AMPHOTERICIN B,N/A,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 17:23:21,1635059561,5/12/2015 17:22:23,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Initial regimen given for,N/A,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 17:39:23,1635074973,5/12/2015 17:37:50,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B,N/a,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 17:44:35,1635080532,5/12/2015 17:44:13,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"CNS BLASTOMYCOSIS: Initial regimen AMPHOTERICIN B weeks, followed fluconazole daily 12 months until CSF abnormalities resolve.",na,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 18:44:15,1635159865,5/12/2015 18:43:59,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 18:48:31,1635166463,5/12/2015 18:47:46,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],regimen,n/a,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 18:49:25,1635167823,5/12/2015 18:49:03,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],Initial regimen of,n/a,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 18:57:32,1635180054,5/12/2015 18:56:38,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],given,N/A,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 19:06:06,1635192984,5/12/2015 19:05:38,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[TREATS],[TREATS],Initial regimen,N/A,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440533,5/12/2015 19:27:15,1635238584,5/12/2015 19:25:53,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",resolve.,n/a,9,43,-1,21,60,TWrex-cause,804238-FS1,"424  CNS BLASTOMYCOSIS: Initial regimen of IV AMPHOTERICIN B given for 4 6 weeks, followed by fluconazole 800 mg daily for at least 12 months and until CSF abnormalities resolve.",BLASTOMYCOSIS,IV AMPHOTERICIN B
720440534,5/12/2015 09:44:54,1634753256,5/12/2015 09:44:23,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],cause,Cause,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 09:51:43,1634758637,5/12/2015 09:50:33,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[PART_OF] [IS_A] [ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]
[OTHER]","RESPIRATORY VIRAL INFECTIONS INFL<span id=""transmark""></span>UENZA",n/a,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 10:19:36,1634777550,5/12/2015 10:18:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],are a leading cause were the most prevalent,N/A,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 10:22:28,1634780107,5/12/2015 10:21:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],leading cause,n/a,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 10:25:48,1634783413,5/12/2015 10:24:06,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A],[IS_A],infectious causes,N/A,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 10:34:59,1634793935,5/12/2015 10:34:09,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],prevalent infectious,none,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 10:57:32,1634817718,5/12/2015 10:57:02,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],most prevalent,n/a,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 11:07:19,1634831389,5/12/2015 11:07:08,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],cause,n/a,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 11:10:43,1634834080,5/12/2015 11:10:11,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[IS_A],[IS_A],RESPIRATORY VIRAL INFECTIONS,N/A,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 11:18:28,1634838775,5/12/2015 11:17:51,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],RESPIRATORY VIRAL INFECTIONS INFLUENZA,n/a,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 11:19:17,1634839089,5/12/2015 11:18:52,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],RESPIRATORY VIRAL INFECTIONS,N/A,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 11:34:31,1634848102,5/12/2015 11:33:22,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[IS_A],[IS_A],the most prevalent infectious causes of death,I did not select 'none'.,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 12:01:53,1634862400,5/12/2015 12:00:26,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 12:09:20,1634865637,5/12/2015 12:08:19,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[IS_A],[IS_A],infectious,N/A,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440534,5/12/2015 13:02:42,1634888432,5/12/2015 13:01:11,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],most prevalent,N/A,116,0,1,124,28,TWrex-cause,812258-FS1,"RESPIRATORY VIRAL INFECTIONS are a leading cause of morbidity, hospitalization, and mortality throughout the world; INFLUENZA and pneumonia were the most prevalent infectious causes of death during the 20th century in the United States.",INFLUENZA,RESPIRATORY VIRAL INFECTIONS
720440535,5/12/2015 14:27:43,1634927451,5/12/2015 14:26:17,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[OTHER],[OTHER],resistant to,resistance is the opposite of treatment.,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 14:37:47,1634932306,5/12/2015 14:37:37,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[CAUSES],[CAUSES],(MDR,;';',9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 14:46:19,1634935921,5/12/2015 14:45:53,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 14:53:27,1634939471,5/12/2015 14:51:41,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],resistant to,N/A,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 14:53:52,1634939738,5/12/2015 14:52:14,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],MTUBERCULOSIS resistant RIFAMPIN,n/a,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 15:22:36,1634969958,5/12/2015 15:21:57,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],resistant to,N/A,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 15:53:29,1635009102,5/12/2015 15:52:44,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],MTUBERCULOSIS resistant to RIFAMPIN,N/A,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 17:14:35,1635055098,5/12/2015 17:13:08,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[OTHER],[OTHER],resistant to both,N/A,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 17:33:40,1635068500,5/12/2015 17:32:59,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],MTUBERCULOSIS resistant to both isoniazid and RIFAMPIN,N/a,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 17:39:09,1635074729,5/12/2015 17:38:53,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],MTUBERCULOSIS resistant both isoniazid RIFAMPIN (MDR TB) occurs.,na,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 18:26:13,1635132754,5/12/2015 18:24:14,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],resistant,N/A,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 18:34:43,1635144887,5/12/2015 18:34:14,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],resistant,n/a,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 18:39:37,1635152071,5/12/2015 18:39:19,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 18:45:55,1635162340,5/12/2015 18:45:23,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],resistant to both,n/a,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440535,5/12/2015 18:51:48,1635171383,5/12/2015 18:49:23,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],resistant,N/A,9,55,-1,20,63,TWrex-cause,804913-FS1,258 ‚Ä¢   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN
720440536,5/12/2015 09:51:40,1634758612,5/12/2015 09:50:47,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],with,Treated with,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 10:03:27,1634766713,5/12/2015 10:02:47,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],"LICE killing PIPERONYL <span id=""transmark""></span>BUTOXIDE",n/a,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 10:32:07,1634790779,5/12/2015 10:31:35,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],killing mousse shampoo kit,N/A,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 10:32:09,1634790810,5/12/2015 10:29:43,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF],[PART_OF],with,N/A,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 10:39:56,1634800472,5/12/2015 10:39:29,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],LICE killing,n/a,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 10:42:34,1634803810,5/12/2015 10:41:41,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],killing,none,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 11:03:40,1634826083,5/12/2015 11:03:14,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],LICE killing kit,n/a,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 11:10:11,1634833664,5/12/2015 11:09:57,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],killing,n/a,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 11:16:32,1634837831,5/12/2015 11:15:50,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],LICE killing,N/A,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 11:23:18,1634840992,5/12/2015 11:22:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],LICE,N/A,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 11:33:36,1634847653,5/12/2015 11:32:58,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],LICE killing shampoo,n/a,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 11:41:10,1634851873,5/12/2015 11:40:41,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[PART_OF],[PART_OF],with,I did not select 'none'.,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 12:37:51,1634878377,5/12/2015 12:37:13,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],killing,N/A,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 13:18:02,1634894853,5/12/2015 13:17:22,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],killing,N/A,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440536,5/12/2015 13:31:56,1634904772,5/12/2015 13:31:38,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],killing,n/a,15,64,-1,18,82,TWrex-cause,800678-FS1,Pronto ¬Æ  plus LICE killing mousse shampoo kit (pyrethrins with PIPERONYL BUTOXIDE product information.,LICE,PIPERONYL BUTOXIDE
720440537,5/12/2015 09:55:14,1634760909,5/12/2015 09:54:42,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 10:08:33,1634769843,5/12/2015 10:07:35,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],"SERTRALINE treatment for PEDIATRIC O<span id=""transmark""></span>CD",n/a,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 10:34:42,1634793547,5/12/2015 10:34:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 10:38:57,1634799234,5/12/2015 10:37:36,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment for,N/A,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 10:46:18,1634808569,5/12/2015 10:45:55,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 10:51:01,1634811623,5/12/2015 10:50:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 11:06:42,1634830541,5/12/2015 11:06:17,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment for,n/a,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 11:18:15,1634838670,5/12/2015 11:17:53,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],SERTRALINE treatment for,N/A,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 11:29:00,1634844320,5/12/2015 11:27:53,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PEDIATRIC OCD,N/A,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 11:36:42,1634849274,5/12/2015 11:36:12,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment for,n/a,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 11:44:53,1634854039,5/12/2015 11:44:07,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],treatment for,I did not select 'none'.,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 12:41:15,1634880016,5/12/2015 12:40:54,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],treatment,N/A,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 13:23:18,1634897476,5/12/2015 13:22:40,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment for,N/A,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 13:33:28,1634905681,5/12/2015 13:33:15,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440537,5/12/2015 13:55:53,1634914788,5/12/2015 13:55:21,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment for,N/A,96,71,-1,108,81,TWrex-cause,800316-FS1,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE
720440538,5/12/2015 09:41:38,1634750483,5/12/2015 09:41:10,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,Associated with,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 09:44:38,1634753039,5/12/2015 09:43:47,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],characterized by PAIN,n/a,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 09:44:38,1634753041,5/12/2015 09:42:53,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[MANIFESTATION] [OTHER] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[OTHER]","VULVODYNIA is characterized by PA<span id=""transmark""></span>IN",n/a,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 10:11:52,1634772200,5/12/2015 10:10:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",characterized by,N/A,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 10:18:33,1634776668,5/12/2015 10:17:49,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],characterized by,n/a,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 10:21:36,1634779477,5/12/2015 10:21:01,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],characterized by,N/A,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 10:30:28,1634788948,5/12/2015 10:30:05,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],characterized,none,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 10:51:43,1634812037,5/12/2015 10:51:26,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",is further by,N/A,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 10:53:58,1634813831,5/12/2015 10:53:29,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],is characterized by,n/a,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 11:06:13,1634829815,5/12/2015 11:05:57,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],occurs,n/a,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 11:17:29,1634838306,5/12/2015 11:16:56,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],PAIN,N/A,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 11:29:31,1634844725,5/12/2015 11:28:51,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[MANIFESTATION],[MANIFESTATION],is further characterized by,I did not select 'none'.,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 11:57:12,1634860338,5/12/2015 11:56:33,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],PAIN,n/a,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 12:04:41,1634863667,5/12/2015 12:04:03,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[SYMPTOM],[SYMPTOM],characterized,N/A,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440538,5/12/2015 12:08:49,1634865441,5/12/2015 12:08:32,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],characterized,n/a,56,5,1,59,15,TWrex-cause,812935-FS1,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA
720440539,5/12/2015 14:18:34,1634923324,5/12/2015 14:17:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],range in severity,N/A,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 14:36:02,1634931329,5/12/2015 14:35:49,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[SYMPTOM],[SYMPTOM],known,jkjkjk,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 14:43:36,1634934795,5/12/2015 14:41:03,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],severity from,N/A,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 14:44:29,1634935173,5/12/2015 14:44:06,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[IS_A],[IS_A],anti,N/A,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 14:45:05,1634935356,5/12/2015 14:44:01,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS reported from MILD DIARRHEA TO FATAL COLITIS.,n/a,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 14:48:04,1634936757,5/12/2015 14:46:50,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"difficile associated diarrhea colitis known ANTIBIOTIC ASSOCIATED DIARRHEA COLITIS pseudomembranous been reported nearly infectives, including lincomycin, range severity MILD DIARRHEA FATAL COLITIS.",na,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 15:18:06,1634964431,5/12/2015 15:17:31,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],"has been reported with nearly all anti infectives,",N/A,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 15:47:47,1635001597,5/12/2015 15:46:49,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS severity from MILD DIARRHEA TO FATAL COLITIS.,N/A,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 15:52:26,1635007632,5/12/2015 15:49:33,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[NONE],[NONE],n/a,both are symptoms of c. difficile.,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 16:46:57,1635041314,5/12/2015 16:46:06,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],severity,n/a,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 17:06:43,1635051501,5/12/2015 17:05:24,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PART_OF],[PART_OF],may range in severity from,N/A,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 17:28:17,1635063365,5/12/2015 17:27:05,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[IS_A],[IS_A],ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS may range in severity from MILD DIARRHEA TO FATAL,N/a,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 18:18:54,1635122581,5/12/2015 18:18:17,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],reported,N/A,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 18:37:25,1635148388,5/12/2015 18:36:47,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440539,5/12/2015 18:42:52,1635157423,5/12/2015 18:42:14,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],"been reported with nearly all anti infectives,",n/a,290,114,1,319,156,TWrex-cause,814681-FS1,"100 ,   101 ,   102 ,   103 ,   104 ,   105    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS or pseudomembranous colitis) has been reported with nearly all anti infectives, including lincomycin, and may range in severity from MILD DIARRHEA TO FATAL COLITIS.",MILD DIARRHEA TO FATAL COLITIS,ANTIBIOTIC ASSOCIATED DIARRHEA AND COLITIS
720440540,5/12/2015 18:50:05,1635168714,5/12/2015 18:49:49,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 18:56:35,1635178447,5/12/2015 18:56:18,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],difficult to treat,n/a,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 19:09:20,1635197923,5/12/2015 19:09:00,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treat,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 19:21:30,1635227561,5/12/2015 19:21:08,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[TREATS],[TREATS],treat,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 19:49:04,1635263299,5/12/2015 19:48:39,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],for difficult to treat,n/a,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 19:53:17,1635266510,5/12/2015 19:52:57,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],difficult to treat,n/a,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 20:07:30,1635278300,5/12/2015 20:06:55,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],MALATHION LOTION to treat HEAD LICE,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 20:23:17,1635290332,5/12/2015 20:22:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 21:08:09,1635319093,5/12/2015 21:07:56,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treat,n/a,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 21:18:26,1635325507,5/12/2015 21:18:09,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],treat,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 21:48:58,1635341815,5/12/2015 21:48:18,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],MALATHION LOTION for difficult to treat HEAD LICE,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 22:13:15,1635359485,5/12/2015 22:12:06,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],MALATHION LOTION for difficult to treat HEAD LICE,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 22:23:56,1635368375,5/12/2015 22:23:18,false,clixsense,1.0,16498372,CAN,ON,Toronto,108.161.124.81,[TREATS],[TREATS],MALATHION LOTION for difficult to treat HEAD LICE,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 22:35:49,1635378730,5/12/2015 22:35:13,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],MALATHION LOTION treat HEAD LICE,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440540,5/12/2015 22:35:53,1635378790,5/12/2015 22:35:30,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],MALATHION LOTION for difficult to treat HEAD LICE,N/A,105,65,-1,113,81,TWrex-cause,804486-FS1,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION
720440541,5/12/2015 20:19:09,1635287318,5/12/2015 20:18:38,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[IS_A],[IS_A],"PAINful conditions, e.g., VULVODYNIA",N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/12/2015 20:49:16,1635307059,5/12/2015 20:48:02,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"The applied mass per area (kg/cm 2 that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/12/2015 21:26:25,1635330383,5/12/2015 21:24:51,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],"e.g.,",n/a,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/12/2015 21:35:56,1635334880,5/12/2015 21:34:17,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[IS_A],[IS_A],"e.g.,",N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/12/2015 22:48:40,1635388462,5/12/2015 22:47:55,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]","PAINful conditions, e.g., VULVODYNIA",N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/12/2015 23:07:02,1635402750,5/12/2015 23:06:09,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"PAINful conditions, e.g., VULVODYNIA",N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/13/2015 00:26:45,1635459214,5/13/2015 00:24:58,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],The mass per area will elicit pain in VULVODYNIA,N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/13/2015 00:36:11,1635466018,5/13/2015 00:35:54,false,elite,1.0,31848723,USA,"","",155.94.185.254,[TREATS],[TREATS],PAINful VULVODYNIA,N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/13/2015 00:52:34,1635478012,5/13/2015 00:51:56,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[IS_A],[IS_A],"will elicit a complaint of pain in subjects with PAINful conditions, e.g., VULVODYNIA",n/a,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/13/2015 02:12:05,1635520922,5/13/2015 02:11:35,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PART_OF],[PART_OF],"subjects with PAINful conditions,",N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/13/2015 03:01:12,1635543847,5/13/2015 03:00:44,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[SYMPTOM],[SYMPTOM],"conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or",no comment,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/13/2015 03:09:37,1635547355,5/13/2015 03:09:12,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [PART_OF] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]","PAINful conditions, or VULVODYNIA",n/a,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/13/2015 03:23:19,1635553782,5/13/2015 03:22:15,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[CAUSES],[CAUSES],complaint of pain,n/a,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/13/2015 03:26:21,1635555101,5/13/2015 03:26:01,false,neodev,1.0,32087449,AUS,02,Sydney,203.31.216.214,[LOCATION],[LOCATION],complaint PAINful,N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440541,5/13/2015 03:28:49,1635556171,5/13/2015 03:28:26,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],"with PAINful conditions, e.g., VULVODYNIA",N/A,91,171,1,94,181,TWrex-cause,814564-FS1,"The applied mass per area (kg/cm 2 ) that will elicit a complaint of pain in subjects with PAINful conditions, e.g., fibromyalgia, temperomandibular joint dysfunction, or VULVODYNIA",PAIN,VULVODYNIA
720440542,5/12/2015 20:17:24,1635286092,5/12/2015 20:16:54,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME,N/A,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/12/2015 20:44:48,1635304109,5/12/2015 20:43:39,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.,N/A,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/12/2015 21:23:11,1635328387,5/12/2015 21:22:44,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],TREATMENT,n/a,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/12/2015 21:32:51,1635333498,5/12/2015 21:32:24,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],TREATMENT of,N/A,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/12/2015 22:45:46,1635386232,5/12/2015 22:45:11,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME,N/A,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/12/2015 22:46:19,1635386640,5/12/2015 22:45:26,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME,N/A,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/13/2015 00:21:28,1635455689,5/13/2015 00:19:49,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME,N/A,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/13/2015 00:34:48,1635465051,5/13/2015 00:33:36,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[SIDE_EFFECT],[SIDE_EFFECT],mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME,n/a,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/13/2015 00:35:09,1635465304,5/13/2015 00:34:41,false,elite,1.0,31848723,USA,"","",155.94.185.254,[SYMPTOM],[SYMPTOM],INTERFERON ZIDOVUDINE TREATMENT ACQUIRED DEFICIENCY SYNDROME,N/A,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/13/2015 01:35:11,1635500985,5/13/2015 01:34:22,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/13/2015 02:10:19,1635520079,5/13/2015 02:09:59,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],TREATMENT of,N/A,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/13/2015 02:59:08,1635542957,5/13/2015 02:58:42,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of,no comment,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/13/2015 03:08:33,1635546868,5/13/2015 03:08:17,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],INTERFERON ALFA AND ZIDOVUDINE TREATMENT ACQUIRED IMMUNE DEFICIENCY SYNDROME,n/a,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/13/2015 03:18:42,1635551634,5/13/2015 03:16:12,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],TREATMENT,n/a,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440542,5/13/2015 03:25:13,1635554578,5/13/2015 03:23:49,false,neodev,1.0,32087449,AUS,02,Sydney,203.31.216.214,[CAUSES],[CAUSES],ACQUIRED DEFICIENCY,N/A,171,127,-1,205,167,TWrex-cause,804006-FS1,"Scadden DT, Bering HA, Levine JD et al. Granulocyte macrophage colony stimulating factor mitigates the neutropenia of combined INTERFERON ALFA AND ZIDOVUDINE TREATMENT of ACQUIRED IMMUNE DEFICIENCY SYNDROME associated Kaposi's sarcoma.",ACQUIRED IMMUNE DEFICIENCY SYNDROME,INTERFERON ALFA AND ZIDOVUDINE TREATMENT
720440543,5/12/2015 16:04:05,1635019325,5/12/2015 16:03:22,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],ERYTHROMYCIN unreliable treatment of SYPHILIS,N/A,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 17:45:50,1635081796,5/12/2015 17:44:43,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],ERYTHROMYCIN treatment of SYPHILIS,N/a,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 18:47:52,1635165413,5/12/2015 18:47:39,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [PREVENTS] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 18:53:14,1635173537,5/12/2015 18:53:01,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment of,n/a,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 18:57:17,1635179686,5/12/2015 18:56:37,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 19:05:03,1635191371,5/12/2015 19:04:36,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 19:14:23,1635208889,5/12/2015 19:13:59,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[TREATS],[TREATS],treatment,N/A,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 19:38:23,1635253687,5/12/2015 19:37:33,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],unreliable for treatment,n/a,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 19:50:38,1635264388,5/12/2015 19:49:06,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",treatment,n/a,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 20:03:07,1635275121,5/12/2015 20:02:40,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CONTRAINDICATES],[CONTRAINDICATES],ERYTHROMYCIN proved unreliable treatment SYPHILIS,N/A,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 20:15:00,1635284461,5/12/2015 20:14:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy,",N/A,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 20:46:46,1635305513,5/12/2015 20:46:24,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treatment of,N/A,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 20:49:33,1635307174,5/12/2015 20:47:07,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",has proved unreliable for treatment,N/A,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 21:05:00,1635317003,5/12/2015 21:04:43,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440543,5/12/2015 21:13:42,1635322588,5/12/2015 21:13:27,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],treatment of,N/A,52,0,-1,59,12,TWrex-cause,803557-FS1,"ERYTHROMYCIN has proved unreliable for treatment of SYPHILIS during pregnancy, and data are lacking on azithromycin or ceftriaxone.",SYPHILIS,ERYTHROMYCIN
720440544,5/12/2015 09:43:27,1634752119,5/12/2015 09:42:52,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],resistance,Resistant to,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 09:48:49,1634756576,5/12/2015 09:48:02,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[CONTRAINDICATES],[CONTRAINDICATES],"resistance to PERMETHRIN in head LI<span id=""transmark""></span>CE",n/a,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 10:16:25,1634774982,5/12/2015 10:15:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],resistance to,N/A,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 10:20:39,1634778628,5/12/2015 10:19:47,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],resistance to,n/a,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 10:23:16,1634780927,5/12/2015 10:22:38,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[MANIFESTATION],[MANIFESTATION],double resistance,N/A,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 10:33:08,1634791771,5/12/2015 10:32:09,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[OTHER],[OTHER],resistance,none,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 10:52:39,1634812804,5/12/2015 10:52:12,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",Evidence for double resistance to,N/A,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 10:56:30,1634816585,5/12/2015 10:54:52,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[OTHER],[OTHER],double resistance to,n/a,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 11:06:53,1634830852,5/12/2015 11:06:40,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],resistance,n/a,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 11:17:14,1634838187,5/12/2015 11:16:49,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],double resistance to,n/a,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 11:18:36,1634838846,5/12/2015 11:18:12,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],head LICE,N/A,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 11:32:27,1634846891,5/12/2015 11:31:32,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[CONTRAINDICATES],[CONTRAINDICATES],double resistance to in,I did not select 'none'.,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 11:59:37,1634861342,5/12/2015 11:58:31,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],and head,n/a,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 12:07:08,1634864695,5/12/2015 12:06:37,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[OTHER],[OTHER],resistance,N/A,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440544,5/12/2015 12:55:16,1634885801,5/12/2015 12:53:19,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],Evidence for double resistance to,N/A,107,74,-1,110,84,TWrex-cause,804406-FS1,"Downs AMR, Stafford KA, Harvey I et al. Evidence for double resistance to PERMETHRIN and malathion in head LICE",LICE,PERMETHRIN
720440545,5/12/2015 09:46:36,1634754686,5/12/2015 09:45:55,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[IS_A],[IS_A],is,Is a,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 09:54:16,1634760217,5/12/2015 09:52:57,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[CAUSES],[CAUSES],"TRICHURIASIS is infection with TRICHURIS TRI<span id=""transmark""></span>CHIURA",the latter causes the earlier in this case,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 10:21:24,1634779382,5/12/2015 10:20:29,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],is infection with,N/A,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 10:26:43,1634784438,5/12/2015 10:26:09,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A],[IS_A],is infection,N/A,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 10:35:42,1634794785,5/12/2015 10:35:13,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],is infection with,n/a,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 10:36:18,1634795632,5/12/2015 10:35:48,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],infection with,none,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 10:59:29,1634820154,5/12/2015 10:58:21,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],is infection with,n/a,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 11:07:52,1634832118,5/12/2015 11:07:38,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],with,n/a,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 11:11:30,1634834645,5/12/2015 11:11:03,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[CAUSES],[CAUSES],infection with,N/A,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 11:19:43,1634839379,5/12/2015 11:19:07,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],infection with,n/a,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 11:20:14,1634839698,5/12/2015 11:19:33,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],TRICHURIASIS,N/A,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 11:36:31,1634849178,5/12/2015 11:35:58,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[IS_A],[IS_A],is infection with,I did not select 'none'.,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 12:03:56,1634863302,5/12/2015 12:03:42,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],infection with,n/a,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 12:10:20,1634866144,5/12/2015 12:09:56,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[CAUSES],[CAUSES],infection with,N/A,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440545,5/12/2015 13:05:50,1634889703,5/12/2015 13:03:48,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],infection,N/A,0,87,1,11,106,TWrex-cause,812426-FS1,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA
720440546,5/12/2015 09:50:20,1634757656,5/12/2015 09:50:00,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treatment of,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 10:02:04,1634765976,5/12/2015 10:00:36,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],"AMOXICILLIN treatment of SOFT TISSUE INF<span id=""transmark""></span>ECTIONS",even if we're six feet underground I know that we'll be safe and sound....,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 10:29:16,1634787512,5/12/2015 10:28:56,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 10:31:06,1634789686,5/12/2015 10:30:50,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment of,N/A,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 10:38:49,1634799016,5/12/2015 10:38:32,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 10:41:19,1634802266,5/12/2015 10:40:38,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 11:02:47,1634824715,5/12/2015 11:02:32,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for the treatment of,n/a,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 11:09:40,1634833365,5/12/2015 11:09:29,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 11:15:26,1634837199,5/12/2015 11:14:22,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],for the treatment,N/A,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 11:22:14,1634840618,5/12/2015 11:22:02,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],SOFT TISSUE,N/A,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 11:32:32,1634846945,5/12/2015 11:32:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,n/a,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 11:40:09,1634851055,5/12/2015 11:39:49,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],for the treatment of,I did not select 'none'.,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 12:36:52,1634877934,5/12/2015 12:36:29,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],treatment,N/A,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 13:16:53,1634894421,5/12/2015 13:16:32,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440546,5/12/2015 13:31:24,1634904312,5/12/2015 13:31:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment of,n/a,63,0,-1,84,11,TWrex-cause,800965-FS1,AMOXICILLIN combined with clavulanic acid for the treatment of SOFT TISSUE INFECTIONS in children.,SOFT TISSUE INFECTIONS,AMOXICILLIN
720440547,5/12/2015 09:50:45,1634757915,5/12/2015 09:50:22,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],therapy,Treated with,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 10:02:46,1634766320,5/12/2015 10:02:05,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],"CYCLOPHOSPHAMIDE therapy in LUP<span id=""transmark""></span>US NEPHRITIS",cyclophosphamide treats luphus nephritis,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 10:29:38,1634788000,5/12/2015 10:29:20,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],therapy,N/A,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 10:31:32,1634790153,5/12/2015 10:31:08,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],therapy in,N/A,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 10:39:28,1634799882,5/12/2015 10:38:49,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy,n/a,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 10:41:41,1634802675,5/12/2015 10:41:20,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],therapy,none,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 11:03:13,1634825422,5/12/2015 11:02:48,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],therapy,n/a,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 11:09:56,1634833487,5/12/2015 11:09:41,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],therapy,n/a,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 11:15:48,1634837471,5/12/2015 11:15:26,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],therapy in a serious case,N/A,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 11:22:31,1634840721,5/12/2015 11:22:15,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],CYCLOPHOSPHAMIDE,N/A,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 11:32:57,1634847212,5/12/2015 11:32:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],therapy,n/a,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 11:40:40,1634851510,5/12/2015 11:40:10,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],therapy,I did not select 'none'.,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 12:37:12,1634878022,5/12/2015 12:36:53,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],therapy,N/A,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 13:17:21,1634894609,5/12/2015 13:16:54,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],therapy,N/A,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440547,5/12/2015 13:31:37,1634904447,5/12/2015 13:31:25,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],therapy,n/a,58,12,-1,72,28,TWrex-cause,804099-FS1,2006 11 01  CYCLOPHOSPHAMIDE therapy in a serious case of LUPUS NEPHRITIS during pregnancy.,LUPUS NEPHRITIS,CYCLOPHOSPHAMIDE
720440548,5/12/2015 09:58:15,1634763303,5/12/2015 09:57:56,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 10:12:52,1634772662,5/12/2015 10:12:32,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]","ERYTHROMYCIN for treatment and prevention of PERT<span id=""transmark""></span>USSIS",n/a,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 10:36:58,1634796499,5/12/2015 10:36:37,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treatment and prevention,N/A,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 10:43:04,1634804436,5/12/2015 10:42:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treatment and prevention of,N/A,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 10:48:40,1634809971,5/12/2015 10:48:19,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treatment prevention,none,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 10:52:55,1634813005,5/12/2015 10:52:30,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",treatment prevention,n/a,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 11:08:45,1634832726,5/12/2015 11:08:19,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",for treatment and prevention of,n/a,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 11:19:25,1634839211,5/12/2015 11:19:11,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",for treatment and prevention,N/A,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 11:33:19,1634847477,5/12/2015 11:32:55,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PERTUSSIS,N/A,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 11:39:12,1634850653,5/12/2015 11:38:50,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treatment and prevention,n/a,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 11:48:06,1634855824,5/12/2015 11:47:48,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",for treatment and prevention of,I did not select 'none'.,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 12:42:51,1634880747,5/12/2015 12:42:32,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treatment prevention,N/A,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 13:28:38,1634901736,5/12/2015 13:28:12,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treatment and prevention,N/A,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 13:34:36,1634906124,5/12/2015 13:34:25,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440548,5/12/2015 14:05:02,1634918175,5/12/2015 14:04:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",for treatment and prevention,N/A,45,0,-1,53,12,TWrex-cause,804254-FS1,ERYTHROMYCIN for treatment and prevention of PERTUSSIS,PERTUSSIS,ERYTHROMYCIN
720440549,5/12/2015 16:02:41,1635018495,5/12/2015 16:01:33,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MYOCARDIAL INFARCTION in patients on ASPIRIN,N/A,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 17:44:02,1635079859,5/12/2015 17:43:16,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[PREVENTS],[PREVENTS],prevention MYOCARDIAL INFARCTION ASPIRIN,N/a,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 18:47:11,1635164196,5/12/2015 18:46:53,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 18:52:38,1635172763,5/12/2015 18:52:12,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],secondary prevention after,n/a,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 18:55:58,1635177588,5/12/2015 18:55:40,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],prevention,n/a,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 19:02:03,1635187210,5/12/2015 19:01:38,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],prevention,N/A,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 19:11:39,1635201974,5/12/2015 19:10:53,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[TREATS] [OTHER],"[TREATS]
[OTHER]",patients on ASPIRIN,N/A,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 19:36:11,1635250747,5/12/2015 19:34:59,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],"remains unclear,",n/a,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 19:48:42,1635262968,5/12/2015 19:48:19,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in patients on,n/a,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 20:02:03,1635274293,5/12/2015 20:01:08,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],patients on ASPIRIN,N/A,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 20:11:30,1635281649,5/12/2015 20:08:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION ASPIRIN remains unclear,",N/A,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 20:44:48,1635304097,5/12/2015 20:43:18,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in patients on,N/A,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 20:44:49,1635304101,5/12/2015 20:42:02,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",he most appropriate role of warfarin for secondary prevention,N/A,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 20:56:46,1635311607,5/12/2015 20:56:25,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],prevention,n/a,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440549,5/12/2015 21:12:23,1635321763,5/12/2015 21:10:56,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in patients on,N/A,71,108,-1,91,115,TWrex-cause,805226-FS1,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN
720440550,5/12/2015 20:06:18,1635277455,5/12/2015 20:04:50,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],is not a cure for,n/a,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/12/2015 20:16:25,1635285410,5/12/2015 20:15:50,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CONTRAINDICATES],[CONTRAINDICATES],PODOPHYLLUM RESIN is not a cure for HPV WARTS,N/A,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/12/2015 20:42:25,1635302537,5/12/2015 20:40:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [OTHER],"[DIAGNOSE_BY_TEST_OR_DRUG]
[OTHER]",Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,N/A,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/12/2015 21:20:12,1635326408,5/12/2015 21:19:29,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],cure,n/a,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/12/2015 21:32:05,1635333186,5/12/2015 21:31:19,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SIDE_EFFECT] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",develop during or after therapy with,N/A,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/12/2015 22:44:16,1635385131,5/12/2015 22:43:00,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SIDE_EFFECT],[SIDE_EFFECT],PODOPHYLLUM RESIN not a cure WARTS may develop during after therapy with the drug.,N/A,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/12/2015 22:44:44,1635385460,5/12/2015 22:44:04,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CONTRAINDICATES],[CONTRAINDICATES],PODOPHYLLUM RESIN not a cure WARTS,N/A,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/13/2015 00:17:45,1635453378,5/13/2015 00:16:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],PODOPHYLLUM RESIN WARTS may develop during drug.,N/A,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/13/2015 00:33:10,1635463832,5/13/2015 00:32:22,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[TREATS],[TREATS],PODOPHYLLUM RESIN is not a cure for HPV; HPV WARTS may develop after therapy with the drug.,n/a,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/13/2015 00:34:15,1635464612,5/13/2015 00:33:46,false,elite,1.0,31848723,USA,"","",155.94.185.254,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PODOPHYLLUM RESIN HPV; HPV WARTS,N/A,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/13/2015 01:32:39,1635499216,5/13/2015 01:32:10,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],therapy with the drug.,n/a,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/13/2015 02:09:33,1635519706,5/13/2015 02:09:11,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],therapy with the drug.,N/A,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/13/2015 02:57:41,1635542223,5/13/2015 02:56:59,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[SIDE_EFFECT],[SIDE_EFFECT],is not a cure for HPV; new HPV,no comment,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/13/2015 03:06:47,1635546162,5/13/2015 03:05:56,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],PODOPHYLLUM not a cure HPV; WARTS,n/a,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440550,5/13/2015 03:15:23,1635550238,5/13/2015 03:14:01,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],cure,n/a,77,28,1,81,45,TWrex-cause,811342-FS1,100 ‚Ä¢  Advise patients that PODOPHYLLUM RESIN is not a cure for HPV; new HPV WARTS may develop during or after therapy with the drug.,WARTS,PODOPHYLLUM RESIN
720440551,5/12/2015 09:44:22,1634752875,5/12/2015 09:43:29,false,prodege,1,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],producing,Produces,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 09:50:32,1634757779,5/12/2015 09:48:50,false,clixsense,1,22947672,GBR,"","",88.144.126.61,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]","astrocytomas of the CENTRAL NERVOUS SYSTEM an<span id=""transmark""></span>d HYDROCEPHALUS",n/a,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 10:18:20,1634776495,5/12/2015 10:16:30,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may have,N/A,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 10:21:17,1634779273,5/12/2015 10:20:40,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],producing,n/a,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 10:24:05,1634781730,5/12/2015 10:23:16,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],producing,N/A,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 10:34:08,1634792834,5/12/2015 10:33:09,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],producing,none,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 10:52:57,1634813013,5/12/2015 10:52:40,false,elite,1,31856422,GBR,C9,Workington,92.18.169.149,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",producing,N/A,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 10:57:01,1634817122,5/12/2015 10:56:30,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],producing,n/a,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 11:07:07,1634831140,5/12/2015 11:06:54,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],producing,n/a,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 11:17:50,1634838505,5/12/2015 11:17:15,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[LOCATION],[LOCATION],the CENTRAL NERVOUS SYSTEM,n/a,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 11:18:50,1634838974,5/12/2015 11:18:37,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],astrocytomas,N/A,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 11:33:20,1634847511,5/12/2015 11:32:28,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[CAUSES],[CAUSES],producing,I did not select 'none'.,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 12:00:24,1634861722,5/12/2015 11:59:38,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],CENTRAL NERVOUS SYSTEM,n/a,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 12:08:18,1634865217,5/12/2015 12:07:09,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may have,N/A,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440551,5/12/2015 13:01:09,1634887716,5/12/2015 12:58:28,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[OTHER],[OTHER],producing,N/A,82,160,-1,103,173,TWrex-cause,802597-FS1,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS
720440552,5/12/2015 19:12:24,1635203638,5/12/2015 19:11:27,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[SYMPTOM],[SYMPTOM],characterized,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 19:27:40,1635239212,5/12/2015 19:26:56,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[MANIFESTATION],[MANIFESTATION],characterized by,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 19:54:59,1635268103,5/12/2015 19:54:27,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],development spontaneous,n/a,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 19:55:36,1635268809,5/12/2015 19:53:10,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],the development of spontaneous,n/a,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 20:09:44,1635280114,5/12/2015 20:09:07,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[SYMPTOM],[SYMPTOM],BIRT HOGG DUBE SYNDROME is characterized by PNEUMOTHORAX,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 20:29:39,1635294578,5/12/2015 20:27:59,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"BIRT HOGG DUBE SYNDROME BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 21:09:52,1635320255,5/12/2015 21:09:32,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[MANIFESTATION],[MANIFESTATION],characterized by,n/a,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 21:21:41,1635327407,5/12/2015 21:20:47,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",characterized by,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 22:16:30,1635362143,5/12/2015 22:15:38,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],characterized by,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 22:18:24,1635363650,5/12/2015 22:16:10,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],BIRT HOGG DUBE SYNDROME characterized by development spontaneous PNEUMOTHORAX,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 22:37:23,1635379897,5/12/2015 22:36:57,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],BIRT HOGG DUBE SYNDROME is an autosomal dominant multisystem disorder characterized by the development of spontaneous PNEUMOTHORAX,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 22:38:32,1635380698,5/12/2015 22:37:32,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",BIRT HOGG DUBE SYNDROME characterized by the development of spontaneous PNEUMOTHORAX,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 23:03:11,1635399874,5/12/2015 23:01:19,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",BIRT HOGG DUBE SYNDROME characterized by the development spontaneous PNEUMOTHORAX,n/a,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 23:42:13,1635429232,5/12/2015 23:40:08,false,neodev,1,31294288,GBR,V2,Glasgow,92.0.224.52,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",characterized by the cutaneous triad the development of spontaneous,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440552,5/12/2015 23:50:15,1635435030,5/12/2015 23:48:59,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A],[IS_A],BIRT HOGG DUBE SYNDROME is an autosomal dominant multisystem disorder and PNEUMOTHORAX,N/A,230,4,1,241,27,TWrex-cause,813003-FS1,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME
720440553,5/12/2015 18:57:13,1635179617,5/12/2015 18:56:59,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],therapy for,n/a,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 19:10:15,1635199468,5/12/2015 19:09:55,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],therapy,N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 19:22:56,1635230807,5/12/2015 19:22:35,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[TREATS],[TREATS],therapy,N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 19:51:25,1635264972,5/12/2015 19:51:02,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],therapy for,n/a,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 19:54:04,1635267187,5/12/2015 19:53:50,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],therapy for,n/a,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 20:08:42,1635279226,5/12/2015 20:08:23,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],CEFTAZIDIME therapy for URINARY TRACT INFECTION,N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 20:26:35,1635292713,5/12/2015 20:25:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 21:08:45,1635319466,5/12/2015 21:08:33,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],therapy,n/a,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 21:19:50,1635326213,5/12/2015 21:19:27,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],therapy for,N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 22:14:36,1635360578,5/12/2015 22:13:57,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],therapy,N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 22:15:28,1635361269,5/12/2015 22:14:42,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CEFTAZIDIME therapy for URINARY TRACT INFECTION,N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 22:36:32,1635379316,5/12/2015 22:36:21,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],CEFTAZIDIME therapy for URINARY TRACT INFECTION,N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 22:36:55,1635379586,5/12/2015 22:36:34,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],CEFTAZIDIME therapy for URINARY TRACT INFECTION,N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 22:57:23,1635395521,5/12/2015 22:56:59,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[TREATS],[TREATS],CEFTAZIDIME therapy for URINARY TRACT INFECTION,n/a,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440553,5/12/2015 23:39:17,1635427006,5/12/2015 23:38:40,false,neodev,1.0,31294288,GBR,V2,Glasgow,92.0.224.52,[TREATS] [CONTRAINDICATES],"[TREATS]
[CONTRAINDICATES]",therapy for,N/A,115,91,-1,137,102,TWrex-cause,804017-FS1,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME
720440554,5/12/2015 09:41:09,1634750157,5/12/2015 09:40:07,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[MANIFESTATION],[MANIFESTATION],resistant,Resistance,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 09:42:52,1634751589,5/12/2015 09:40:13,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[CONTRAINDICATES] [OTHER],"[CONTRAINDICATES]
[OTHER]","CHLOROQUINE resistant P. falciparum MAL<span id=""transmark""></span>ARIA",n/a,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 09:43:46,1634752320,5/12/2015 09:41:28,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],CHLOROQUINE resistant,n/a,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 09:45:01,1634753374,5/12/2015 09:42:02,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[NONE],[NONE],[NONE[,The malaria is RESISTENT to  chloroquine,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 10:10:34,1634771203,5/12/2015 10:09:47,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],resistant,N/A,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 10:17:48,1634775968,5/12/2015 10:17:08,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],prevention,n/a,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 10:21:00,1634778906,5/12/2015 10:20:39,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CONTRAINDICATES],[CONTRAINDICATES],resistant,N/A,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 10:30:05,1634788465,5/12/2015 10:29:29,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],prevention,none,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 10:51:25,1634811882,5/12/2015 10:51:10,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",resistant,N/A,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 10:53:28,1634813373,5/12/2015 10:52:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],"For prevention of malaria,",n/a,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 11:05:55,1634829362,5/12/2015 11:05:41,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevention,n/a,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 11:16:56,1634838032,5/12/2015 11:16:33,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[MANIFESTATION],[MANIFESTATION],CHLOROQUINE,N/A,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 11:28:49,1634844189,5/12/2015 11:27:14,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[OTHER],[OTHER],resistant,A is one of the possible variations of malaria.,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 11:56:32,1634860014,5/12/2015 11:56:06,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],individuals traveling,n/a,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440554,5/12/2015 12:03:13,1634862972,5/12/2015 12:01:33,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[OTHER],[OTHER],resistant,N/A,138,100,-1,144,111,TWrex-cause,804778-FS1,"105 ,   109   For prevention of malaria, use only in individuals traveling to malarious areas where CHLOROQUINE resistant  P. falciparum  MALARIA has  not  been reported.",MALARIA,CHLOROQUINE
720440555,5/12/2015 09:49:58,1634757422,5/12/2015 09:49:12,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,Associated with,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 10:00:34,1634765168,5/12/2015 09:58:12,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[MANIFESTATION] [PART_OF],"[MANIFESTATION]
[PART_OF]","WERNICKE ENCEPHALOPATHY include FLUCTUATING CONFUSIONAL ST<span id=""transmark""></span>ATES",n/a,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 10:28:53,1634787068,5/12/2015 10:27:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",features of,N/A,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 10:30:50,1634789311,5/12/2015 10:29:55,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],which include,N/A,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 10:38:31,1634798595,5/12/2015 10:37:57,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],features of,n/a,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 10:40:36,1634801332,5/12/2015 10:39:41,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],include,none,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 11:02:32,1634824320,5/12/2015 11:01:37,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM],[SYMPTOM],which include,n/a,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 11:09:28,1634833292,5/12/2015 11:09:16,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 11:14:21,1634836564,5/12/2015 11:14:06,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",which include,N/A,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 11:22:01,1634840525,5/12/2015 11:21:29,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],"palsies,",N/A,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 11:28:30,1634844018,5/12/2015 11:28:02,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],hallmark features,n/a,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 11:39:48,1634850904,5/12/2015 11:38:53,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[SYMPTOM],[SYMPTOM],features which include,I did not select 'none'.,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 12:36:27,1634877741,5/12/2015 12:35:27,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[SYMPTOM],[SYMPTOM],"features in rare cases,",N/A,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 13:16:30,1634894254,5/12/2015 13:14:22,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],which include,N/A,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440555,5/12/2015 13:31:09,1634904101,5/12/2015 13:30:46,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],hallmark features,n/a,254,79,1,283,102,TWrex-cause,813889-FS1,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY
720440556,5/12/2015 19:31:20,1635244524,5/12/2015 19:30:19,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[CAUSES],[CAUSES],known to cause,N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 19:56:37,1635269837,5/12/2015 19:56:21,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],cause,n/a,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 19:59:30,1635272469,5/12/2015 19:58:41,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],to cause,n/a,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 20:12:04,1635282058,5/12/2015 20:11:37,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CAUSES],[CAUSES],DRUGS are known to cause IMPAIRED GLUCOSE TOLERANCE,N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 20:35:11,1635297997,5/12/2015 20:34:13,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]","DRUGS Chemical Agents, and Toxins INTRODUCTION Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes",N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 21:17:22,1635324938,5/12/2015 21:16:57,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],cause,n/a,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 21:26:54,1635330583,5/12/2015 21:26:24,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],cause,N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 22:36:34,1635379345,5/12/2015 22:35:19,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],DRUGS are known to cause IMPAIRED GLUCOSE TOLERANCE,N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 22:39:20,1635381289,5/12/2015 22:38:38,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SIDE_EFFECT],[SIDE_EFFECT],DRUGS Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE,N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 22:41:33,1635382946,5/12/2015 22:40:45,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CAUSES],[CAUSES],DRUGS are known to cause IMPAIRED GLUCOSE TOLERANCE,N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/12/2015 23:47:39,1635433322,5/12/2015 23:46:37,false,neodev,1.0,31294288,GBR,V2,Glasgow,92.0.224.52,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",and Toxins Many pharmaceutical agents are known to cause,N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/13/2015 00:03:29,1635444250,5/13/2015 00:02:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],DRUGS are known to cause IMPAIRED GLUCOSE TOLERANCE,N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/13/2015 00:14:39,1635451188,5/13/2015 00:13:51,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[NONE],[NONE],n/a,"""Introduction"" is irrelevant to the medical terminology",95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/13/2015 00:32:16,1635463168,5/13/2015 00:31:41,false,elite,1.0,31848723,USA,"","",155.94.185.254,[CAUSES],[CAUSES],DRUGS INTRODUCTION IMPAIRED GLUCOSE TOLERANCE,N/A,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440556,5/13/2015 01:28:14,1635496910,5/13/2015 01:27:17,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],are known to cause,n/a,95,0,1,120,5,TWrex-cause,810018-FS1,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS
720440557,5/12/2015 17:49:51,1635086260,5/12/2015 17:48:21,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[IS_A],[IS_A],HEPATITIS C INFECTION is HEPATITIS C,N/a,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 18:49:28,1635167876,5/12/2015 18:48:54,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 18:55:35,1635176966,5/12/2015 18:55:07,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"may be asymptomatic,",n/a,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 19:08:18,1635196418,5/12/2015 19:07:19,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],obtained.,N/A,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 19:19:10,1635221181,5/12/2015 19:18:33,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[OTHER],[OTHER],serum markers,N/A,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 19:46:52,1635261691,5/12/2015 19:44:38,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[IS_A],[IS_A],is common,n/a,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 19:52:37,1635265881,5/12/2015 19:52:02,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEPATITIS C INFECTION HEPATITIS,n/a,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 20:06:27,1635277530,5/12/2015 20:05:36,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEPATITIS C INFECTION is common for HEPATITIS C,N/A,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 20:20:42,1635288371,5/12/2015 20:18:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C",N/A,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 20:50:39,1635307847,5/12/2015 20:49:40,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[NONE],[NONE],N/A,It's the same.,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 21:07:21,1635318683,5/12/2015 21:06:37,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],markers,n/a,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 21:11:08,1635321049,5/12/2015 21:08:46,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",serum markers,N/A,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 21:17:34,1635325072,5/12/2015 21:16:05,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[IS_A] [NONE],"[IS_A]
[NONE]",N/A,Both terms are equivalent.,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 21:46:10,1635340454,5/12/2015 21:44:30,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],"HEPATITIS C INFECTION may be asymptomatic, serum markers for HEPATITIS C should be obtained.",N/A,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440557,5/12/2015 22:11:18,1635357964,5/12/2015 22:09:46,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[CAUSES],[CAUSES],HEPATITIS C INFECTION HEPATITIS C,N/A,19,19,1,39,30,TWrex-cause,811507-FS1,"Because concurrent HEPATITIS C INFECTION is common and may be asymptomatic, serum markers for HEPATITIS C (see    ) should be obtained.",HEPATITIS C INFECTION,HEPATITIS C
720440558,5/12/2015 14:42:38,1634934369,5/12/2015 14:42:12,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[SYMPTOM],[SYMPTOM],of,ghh,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 14:50:07,1634937732,5/12/2015 14:49:50,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 15:04:48,1634948766,5/12/2015 15:03:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],FACTOR VII (RFVIIA) treatment of HEMOPHILIA A,n/a,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 15:10:55,1634955275,5/12/2015 15:09:45,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for the treatment of,N/A,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 15:29:03,1634977904,5/12/2015 15:28:38,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment of,N/A,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 16:01:32,1635017895,5/12/2015 16:00:55,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],FACTOR VII (RFVIIA) treatment of HEMOPHILIA,N/A,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 17:28:13,1635063300,5/12/2015 17:27:37,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment of,N/A,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 17:43:14,1635078909,5/12/2015 17:42:43,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],FACTOR VII (RFVIIA) for the treatment of HEMOPHILIA A,N/a,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 17:48:42,1635084940,5/12/2015 17:47:51,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"FACTOR VIIA Recombinant FACTOR VII (RFVIIA) approved treatment bleeding episodes patients HEMOPHILIA A B antibodies (inhibitors) factor VIII IX,",na,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 18:46:49,1635163650,5/12/2015 18:46:31,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 18:52:11,1635172026,5/12/2015 18:51:54,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment of,n/a,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 18:55:39,1635177070,5/12/2015 18:54:59,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 19:01:37,1635186475,5/12/2015 19:01:10,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 19:10:51,1635200295,5/12/2015 19:09:48,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[TREATS],[TREATS],treatment,N/A,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440558,5/12/2015 19:34:59,1635249151,5/12/2015 19:34:28,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],treatment of bleeding episodes,n/a,131,35,-1,142,54,TWrex-cause,800617-FS1,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA)
720440559,5/12/2015 20:19:46,1635287725,5/12/2015 20:19:11,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ITP with PERSISTENT SEVERE THROMBOCYTOPENIA,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/12/2015 20:50:47,1635307900,5/12/2015 20:49:17,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",recommended for patients with persistent platelet counts 9 cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count 9 cells/L) despite treatment.,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/12/2015 21:26:51,1635330571,5/12/2015 21:26:27,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/12/2015 21:37:24,1635335710,5/12/2015 21:35:57,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",patients with,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/12/2015 22:49:09,1635388785,5/12/2015 22:48:41,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],recommended for patients ITP PERSISTENT SEVERE THROMBOCYTOPENIA,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/12/2015 23:07:56,1635403543,5/12/2015 23:07:04,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],ITP with PERSISTENT SEVERE THROMBOCYTOPENIA,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/13/2015 00:34:08,1635464515,5/13/2015 00:33:04,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH],[ASSOCIATED_WITH],patients who have ITP with PERSISTENT SEVERE THROMBOCYTOPENIA,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/13/2015 00:36:37,1635466316,5/13/2015 00:36:13,false,elite,1.0,31848723,USA,"","",155.94.185.254,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PERSISTENT SEVERE THROMBOCYTOPENIA,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/13/2015 00:53:17,1635478511,5/13/2015 00:52:35,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[ASSOCIATED_WITH] [SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",ITP with PERSISTENT SEVERE THROMBOCYTOPENIA despite treatment.,n/a,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/13/2015 02:12:36,1635521165,5/13/2015 02:12:06,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/13/2015 03:01:39,1635544032,5/13/2015 03:01:14,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[SYMPTOM],[SYMPTOM],for 3 months with,no comment,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/13/2015 03:09:56,1635547549,5/13/2015 03:09:38,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[MANIFESTATION] [ASSOCIATED_WITH] [PART_OF],"[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",ITP with PERSISTENT SEVERE THROMBOCYTOPENIA,n/a,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/13/2015 03:24:24,1635554246,5/13/2015 03:23:21,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[ASSOCIATED_WITH],[ASSOCIATED_WITH],who have had with,n/a,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/13/2015 03:26:45,1635555219,5/13/2015 03:26:23,false,neodev,1.0,32087449,AUS,02,Sydney,203.31.216.214,[CAUSES],[CAUSES],THROMBOCYTOPENIA despite,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440559,5/13/2015 03:33:20,1635558056,5/13/2015 03:33:02,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ITP with PERSISTENT SEVERE THROMBOCYTOPENIA,N/A,165,143,1,198,146,TWrex-cause,814188-FS1,‚Ä¢ Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP
720440560,5/12/2015 14:25:56,1634926728,5/12/2015 14:23:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,The two are one in the same referring to the same bacteria just a synonym.,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 14:37:18,1634932050,5/12/2015 14:37:07,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[LOCATION],[LOCATION],appropriate,kl;l;,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 14:45:36,1634935590,5/12/2015 14:45:18,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 14:50:34,1634937989,5/12/2015 14:48:34,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],are prevalent of suspected,N/A,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 14:50:37,1634938041,5/12/2015 14:49:29,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],STAPHYLOCOCCI) are STAPHYLOCOCCAL INFECTIONS,n/a,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 15:21:35,1634968832,5/12/2015 15:19:34,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI),N/A,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 15:51:27,1635006316,5/12/2015 15:50:10,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],STAPHYLOCOCCI) prevalent in empiric therapy STAPHYLOCOCCAL INFECTIONS,N/A,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 16:52:31,1635044399,5/12/2015 16:50:28,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,n/a,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 17:11:55,1635054114,5/12/2015 17:10:35,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",of suspected,N/A,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 17:32:32,1635067303,5/12/2015 17:31:38,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[PART_OF],[PART_OF],If staphylococci resistant to penicillinase empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS,N/a,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 17:38:37,1635074078,5/12/2015 17:38:16,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"staphylococci resistant penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) prevalent hospital community, empiric therapy suspected STAPHYLOCOCCAL INFECTIONS include anti infective vancomycin.",na,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 18:23:36,1635129279,5/12/2015 18:22:29,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF],[PART_OF],suspected,N/A,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 18:38:56,1635150920,5/12/2015 18:38:34,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [SYMPTOM] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 18:44:48,1635160744,5/12/2015 18:44:24,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],should include another,n/a,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440560,5/12/2015 18:48:56,1635167184,5/12/2015 18:48:03,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],empiric therapy,N/A,203,115,1,227,128,TWrex-cause,811075-FS1,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI) are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI
720440561,5/12/2015 09:47:53,1634755747,5/12/2015 09:47:06,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],the,Associated with,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 09:56:27,1634761963,5/12/2015 09:55:19,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[OTHER] [LOCATION],"[LOCATION]
[OTHER]","Examination of SCALP may reveal LI<span id=""transmark""></span>CE",n/a,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 10:23:44,1634781390,5/12/2015 10:22:48,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[LOCATION],[LOCATION],may reveal,N/A,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 10:28:48,1634786999,5/12/2015 10:27:39,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[LOCATION],[LOCATION],may reveal,N/A,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 10:37:07,1634796672,5/12/2015 10:36:38,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[LOCATION] [SYMPTOM],"[LOCATION]
[SYMPTOM]",itchy SCALP,n/a,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 10:37:59,1634797799,5/12/2015 10:37:19,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],reveal,none,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 11:00:36,1634821540,5/12/2015 11:00:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[LOCATION] [SYMPTOM],"[LOCATION]
[SYMPTOM]",itchy SCALP may reveal,n/a,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 11:08:40,1634832647,5/12/2015 11:08:10,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may,n/a,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 11:12:19,1634835184,5/12/2015 11:11:57,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[LOCATION],[LOCATION],Examination of the itchy SCALP,N/A,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 11:21:01,1634840008,5/12/2015 11:20:41,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],LICE,N/A,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 11:27:07,1634843235,5/12/2015 11:26:34,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[LOCATION],[LOCATION],Examination of the itchy SCALP may reveal,n/a,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 11:37:48,1634849838,5/12/2015 11:37:17,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[LOCATION],[LOCATION],may reveal the,I did not select 'none'.,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 12:11:36,1634866610,5/12/2015 12:10:52,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[LOCATION],[LOCATION],Examination may reveal,N/A,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 13:10:10,1634891605,5/12/2015 13:08:19,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[LOCATION],[LOCATION],Examination,N/A,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440561,5/12/2015 13:30:13,1634903171,5/12/2015 13:29:53,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[LOCATION],[LOCATION],Examination,n/a,30,51,-1,34,55,TWrex-cause,802881-FS1,"23   Examination of the itchy SCALP may reveal the LICE which look like tiny black dots that are barely visible to the naked eye, and lice eggs (nits), which are white and are attached to the hair shafts [ see Figure 4.",SCALP,LICE
720440562,5/12/2015 13:38:31,1634907832,5/12/2015 13:38:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],characterized by,n/a,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 14:17:13,1634922673,5/12/2015 14:16:41,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],characterized by,N/A,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 14:35:42,1634931169,5/12/2015 14:35:30,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[LOCATION],[LOCATION],characterized,jkjkk,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 14:40:28,1634933438,5/12/2015 14:39:45,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],ACUTE PORPHYRIA characterized by FLACCID PARALYSIS,n/a,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 14:41:02,1634933646,5/12/2015 14:40:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],characterized by,N/A,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 14:44:04,1634934966,5/12/2015 14:43:37,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and by,N/A,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 14:46:48,1634936145,5/12/2015 14:46:23,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],porphyric Polyneuropathy resulting ACUTE PORPHYRIA characterized pains paresthesias extremities FLACCID PARALYSIS,na,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 15:17:30,1634963571,5/12/2015 15:17:14,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],characterized by,N/A,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 15:35:26,1634985987,5/12/2015 15:35:03,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],ACUTE PORPHYRIA characterized by FLACCID PARALYSIS,N/A,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 15:46:48,1635000243,5/12/2015 15:46:04,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],ACUTE PORPHYRIA characterized by FLACCID PARALYSIS,N/A,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 15:49:32,1635003769,5/12/2015 15:48:11,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[SYMPTOM],[SYMPTOM],characterized by,n/a,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 16:24:48,1635029925,5/12/2015 16:23:58,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],characterized by,N/A,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 16:46:04,1635040797,5/12/2015 16:45:30,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],extremities,n/a,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 17:05:21,1635050824,5/12/2015 17:04:42,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],characterized by,N/A,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440562,5/12/2015 17:27:03,1635062333,5/12/2015 17:26:39,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[SYMPTOM],[SYMPTOM],characterized by,N/a,129,47,1,145,62,TWrex-cause,812686-FS1,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA
720440563,5/12/2015 13:31:42,1634904559,5/12/2015 13:31:02,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 13:35:35,1634906555,5/12/2015 13:35:19,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 14:10:36,1634920247,5/12/2015 14:09:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 14:25:35,1634926595,5/12/2015 14:25:14,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],FACTOR VIII HEMOPHILIA A OR B treatment,n/a,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 14:27:49,1634927482,5/12/2015 14:26:31,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for treatment,N/A,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 14:32:58,1634929777,5/12/2015 14:32:44,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[SYMPTOM],[SYMPTOM],patients,hjhj,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 14:32:59,1634929807,5/12/2015 14:32:05,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Administer treatment,N/A,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 14:33:13,1634929938,5/12/2015 14:32:45,false,prodege,1.0,2145087,USA,NY,New York,107.107.63.230,[CONTRAINDICATES] [TREATS],"[TREATS]
[CONTRAINDICATES]",for treatment of,N/A,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 14:34:23,1634930541,5/12/2015 14:33:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],Administer FACTOR VIII in patients with HEMOPHILIA A OR B,n/a,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 14:40:18,1634933366,5/12/2015 14:39:47,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 14:41:48,1634934035,5/12/2015 14:41:17,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],DRUG THERAPY Introduction Administer FACTOR VIII factor IX replacement patients HEMOPHILIA A B treatment prophylaxis against bleeding.,na,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 15:13:16,1634958138,5/12/2015 15:12:11,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],Administer FACTOR in patients with HEMOPHILIA,N/A,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 15:28:40,1634977432,5/12/2015 15:27:26,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",FACTOR VIII HEMOPHILIA treatment prophylaxis,I didn't select NONE,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 15:30:00,1634979066,5/12/2015 15:29:25,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",Administer FACTOR VIII in patients HEMOPHILIA for treatment of or prophylaxis against bleeding.,N/A,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440563,5/12/2015 15:30:28,1634979693,5/12/2015 15:29:40,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],in patients with,n/a,93,39,-1,109,50,TWrex-cause,803578-FS1,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII
720440564,5/12/2015 13:36:52,1634907053,5/12/2015 13:36:36,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],from,n/a,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 14:12:58,1634921031,5/12/2015 14:11:50,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],In vitro activities,N/A,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 14:27:11,1634927265,5/12/2015 14:26:56,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],YERSINIA PESTIS from a SOUTHERN AFRICAN PLAGUE,n/a,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 14:34:07,1634930398,5/12/2015 14:33:55,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[MANIFESTATION],[MANIFESTATION],human,jhj,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 14:34:30,1634930600,5/12/2015 14:33:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PART_OF],[PART_OF],isolates of YERSINIA PESTIS from a,N/A,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 14:37:11,1634932017,5/12/2015 14:36:13,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],YERSINIA PESTIS from a SOUTHERN AFRICAN PLAGUE,n/a,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 14:37:50,1634932310,5/12/2015 14:36:33,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],from a,N/A,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 14:41:43,1634934007,5/12/2015 14:41:23,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 14:43:32,1634934720,5/12/2015 14:43:13,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Frean Arntzen Capper In vitro activities 14 antibiotics 100 human isolates YERSINIA PESTIS SOUTHERN AFRICAN PLAGUE focus.,na,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 15:15:30,1634960916,5/12/2015 15:14:59,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],YERSINIA PESTIS from a SOUTHERN AFRICAN PLAGUE,N/A,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 15:32:02,1634981692,5/12/2015 15:31:32,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[PART_OF],[PART_OF],from a,n/a,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 15:33:13,1634983118,5/12/2015 15:32:21,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],human isolates of YERSINIA PESTIS from a SOUTHERN AFRICAN PLAGUE focus.,N/A,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 15:40:52,1634992519,5/12/2015 15:38:35,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[PART_OF],[PART_OF],isolates from a,N/A,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 15:41:52,1634993785,5/12/2015 15:41:30,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],antibiotics,n/a,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440564,5/12/2015 15:42:45,1634994977,5/12/2015 15:41:33,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],YERSINIA PESTIS from SOUTHERN AFRICAN PLAGUE focus.,N/A,130,106,1,152,121,TWrex-cause,811511-FS1,"Frean JA, Arntzen L, Capper T et al. In vitro activities of 14 antibiotics against 100 human isolates of  YERSINIA PESTIS  from a SOUTHERN AFRICAN PLAGUE focus.",SOUTHERN AFRICAN PLAGUE,YERSINIA PESTIS
720440565,5/12/2015 09:57:55,1634762985,5/12/2015 09:56:43,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],risk,Reduces risk from,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 10:12:31,1634772452,5/12/2015 10:11:22,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[PREVENTS],[PREVENTS],"Interferon reduce risk for HEPATOCELLULAR CA<span id=""transmark""></span>NCER",n/a,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 10:36:36,1634796014,5/12/2015 10:35:25,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reduce risk,N/A,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 10:42:11,1634803335,5/12/2015 10:41:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],reduce risk,N/A,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 10:48:18,1634809717,5/12/2015 10:47:13,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SIDE_EFFECT],[SIDE_EFFECT],reduce risk,none,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 10:52:28,1634812688,5/12/2015 10:51:57,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],reduce risk,n/a,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 11:08:17,1634832439,5/12/2015 11:07:44,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],reduce risk for,n/a,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 11:19:10,1634839031,5/12/2015 11:18:54,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[PREVENTS],[PREVENTS],reduce risk,N/A,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 11:32:54,1634847194,5/12/2015 11:31:40,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HEPATOCELLULAR CANCER,N/A,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 11:38:49,1634850392,5/12/2015 11:37:47,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],reduce risk,n/a,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 11:47:46,1634855646,5/12/2015 11:47:06,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[PREVENTS],[PREVENTS],reduce risk for,I did not select 'none'.,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 12:42:31,1634880623,5/12/2015 12:42:07,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[PREVENTS],[PREVENTS],reduce risk,N/A,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 13:28:10,1634901405,5/12/2015 13:25:14,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],reduce risk,N/A,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 13:34:24,1634906028,5/12/2015 13:34:06,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],reduce risk,n/a,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440565,5/12/2015 14:04:42,1634918055,5/12/2015 14:04:20,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],reduce risk for,N/A,65,204,-1,85,214,TWrex-cause,800863-FS1,Review: Interferon and nucleoside/tide analogues reduce risk for HEPATOCELLULAR CANCER in patients with chronic hepatitis B  Gastroenterology Infectious Disease  About Star Ratings  Keywords: Hepatitis B INTERFERONs Nucleosides Nucleotides Neoplasms  ACP Journal Club.,HEPATOCELLULAR CANCER,INTERFERON
720440566,5/12/2015 20:04:12,1635275981,5/12/2015 20:02:29,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],by quickly treating,n/a,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/12/2015 20:14:48,1635284323,5/12/2015 20:13:45,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[LOCATION],[LOCATION],PNEUMONIA can seed the LUNG,N/A,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/12/2015 20:39:31,1635300840,5/12/2015 20:38:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,N/A,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/12/2015 21:19:13,1635325899,5/12/2015 21:18:53,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[LOCATION],[LOCATION],sites,n/a,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/12/2015 21:30:40,1635332513,5/12/2015 21:28:41,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,There is a relation but cannot be highlighted by the terms in the sentence.,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/12/2015 22:41:49,1635383172,5/12/2015 22:40:39,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],risk for PNEUMONIA or by treating sites infections that can seed the LUNG,N/A,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/12/2015 22:42:30,1635383764,5/12/2015 22:40:49,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[LOCATION],[LOCATION],PNEUMONIA sites of infections that can seed the LUNG,N/A,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/12/2015 22:43:29,1635384558,5/12/2015 22:43:00,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[LOCATION],[LOCATION],PNEUMONIA infections the LUNG,N/A,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/13/2015 00:15:25,1635451742,5/13/2015 00:14:49,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],causes lung abscess PNEUMONIA,N/A,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/13/2015 00:31:34,1635462702,5/13/2015 00:30:28,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[LOCATION] [SYMPTOM],"[LOCATION]
[SYMPTOM]",not preventable except by decreasing risk for PNEUMONIA by quickly treating sites of infections that can seed the LUNG,n/a,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/13/2015 00:33:19,1635463908,5/13/2015 00:32:59,false,elite,1.0,31848723,USA,"","",155.94.185.254,[SYMPTOM],[SYMPTOM],PNEUMONIA LUNG,N/A,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/13/2015 01:31:54,1635498825,5/13/2015 01:30:57,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[LOCATION],[LOCATION],sites of infections,n/a,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/13/2015 02:08:39,1635519309,5/13/2015 02:07:49,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],causes of,N/A,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/13/2015 02:56:16,1635541671,5/13/2015 02:55:39,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[LOCATION],[LOCATION],by immunizations or by quickly treating extrapulmonary sites of infections that can seed the,no comment,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440566,5/13/2015 03:05:32,1635545588,5/13/2015 03:05:00,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]",PNEUMONIA infections seed the LUNG,n/a,249,146,-1,252,155,TWrex-cause,802767-FS1,‚Ä¢ Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA
720440567,5/12/2015 09:55:32,1634761101,5/12/2015 09:55:16,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 10:10:16,1634771013,5/12/2015 10:08:34,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[CAUSES],[CAUSES],"FLUOXETINE of<span id=""transmark""></span> DEPRESSION","don't believe what they say, fluoxetine not only does nothing to cure depression but actually causes depression to worsen",76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 10:34:57,1634793890,5/12/2015 10:34:45,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 10:40:10,1634800734,5/12/2015 10:39:03,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 10:46:42,1634808784,5/12/2015 10:46:19,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 10:51:23,1634811867,5/12/2015 10:51:02,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 11:06:59,1634830950,5/12/2015 11:06:43,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],approved for the treatment of,n/a,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 11:18:29,1634838783,5/12/2015 11:18:17,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],for the treatment of,N/A,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 11:29:33,1634844737,5/12/2015 11:29:01,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],obesity.,N/A,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 11:37:14,1634849596,5/12/2015 11:36:43,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment,n/a,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 11:45:17,1634854303,5/12/2015 11:44:54,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],is approved for the treatment of,I did not select 'none'.,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 12:41:38,1634880218,5/12/2015 12:41:16,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],treatment,N/A,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 13:23:37,1634897732,5/12/2015 13:23:20,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 13:33:41,1634905769,5/12/2015 13:33:29,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],approved treatment,n/a,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440567,5/12/2015 13:57:05,1634915177,5/12/2015 13:55:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,76,0,-1,85,10,TWrex-cause,803857-FS1,FLUOXETINE at a dose of 20 mg/d is approved by the FDA for the treatment of DEPRESSION but it is not approved by the FDA for treatment of obesity.,DEPRESSION,FLUOXETINE
720440568,5/12/2015 13:33:21,1634905669,5/12/2015 13:32:19,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatments,N/A,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 13:36:09,1634906767,5/12/2015 13:35:54,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatments include,n/a,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 14:11:30,1634920619,5/12/2015 14:11:05,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatments include,N/A,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 14:26:15,1634926813,5/12/2015 14:26:04,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],treatments include VORICONAZOLE in ASPERGILLOSIS,n/a,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 14:31:50,1634929284,5/12/2015 14:30:24,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],current treatments include,N/A,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 14:33:26,1634930043,5/12/2015 14:33:14,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[CAUSES],[CAUSES],Newer,fgfg,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 14:33:58,1634930322,5/12/2015 14:33:37,false,prodege,1.0,2145087,USA,NY,New York,107.107.63.230,[TREATS],[TREATS],in,N/A,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 14:35:02,1634930858,5/12/2015 14:34:05,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatments include,N/A,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 14:35:40,1634931167,5/12/2015 14:34:56,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],VORICONAZOLE and ASPERGILLOSIS,n/a,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 14:41:00,1634933640,5/12/2015 14:40:39,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatments,N/A,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 14:42:47,1634934433,5/12/2015 14:42:13,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Treatment current treatments VORICONAZOLE liposomal amphotericin B. findings suggest mild oral steroids longer period preferably 9 months ASPERGILLOSIS pulmonary segment.,na,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 15:14:34,1634959711,5/12/2015 15:13:49,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],current treatments,N/A,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 15:31:12,1634980636,5/12/2015 15:30:24,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[LOCATION],[LOCATION],The current treatments include VORICONAZOLE in ASPERGILLOSIS in pulmonary segment.,N/A,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 15:31:13,1634980646,5/12/2015 15:30:54,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],The current treatments,n/a,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440568,5/12/2015 15:34:41,1634985025,5/12/2015 15:33:33,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[TREATS],[TREATS],current treatments include,N/A,192,42,-1,204,54,TWrex-cause,800866-FS1,"Treatment  The current treatments include VORICONAZOLE and liposomal amphotericin B. Newer findings suggest use of mild oral steroids for a longer period of time, preferably for 6 9 months in ASPERGILLOSIS in pulmonary segment.",ASPERGILLOSIS,VORICONAZOLE
720440569,5/12/2015 09:42:01,1634750816,5/12/2015 09:41:39,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 09:46:39,1634754762,5/12/2015 09:44:40,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],"SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treat<span id=""transmark""></span>ment of RENAL ANAEMIA",n/a,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 10:13:32,1634773126,5/12/2015 10:11:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 10:18:50,1634776861,5/12/2015 10:18:34,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 10:21:57,1634779725,5/12/2015 10:21:38,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment of,N/A,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 10:31:05,1634789645,5/12/2015 10:30:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 10:34:56,1634793857,5/12/2015 10:33:39,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,n/a,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 10:51:59,1634812213,5/12/2015 10:51:44,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],in the treatment of,N/A,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 10:54:15,1634814027,5/12/2015 10:54:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 11:06:25,1634830073,5/12/2015 11:06:15,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 11:17:50,1634838506,5/12/2015 11:17:31,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],SUBCUTANEOUS RECOMBINANT,N/A,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 11:30:28,1634845525,5/12/2015 11:29:32,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],in the treatment of,I did not select 'none'.,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 11:58:10,1634860757,5/12/2015 11:57:13,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",treatment,n/a,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 12:05:03,1634863855,5/12/2015 12:04:42,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],treatment,N/A,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440569,5/12/2015 12:09:00,1634865541,5/12/2015 12:08:50,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,100,42,-1,112,79,TWrex-cause,803980-FS1,"Macdougall IC, Cavill I, Davies ME et al. SUBCUTANEOUS RECOMBINANT EPOETIN ALFA in the treatment of RENAL ANAEMIA in CAPD patients.",RENAL ANAEMIA,SUBCUTANEOUS RECOMBINANT EPOETIN ALFA
720440570,5/12/2015 14:41:20,1634933858,5/12/2015 14:41:01,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[SYMPTOM],[SYMPTOM],FISTULA,ghh,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 14:49:15,1634937303,5/12/2015 14:48:56,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[LOCATION],[LOCATION],between,N/A,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 15:02:23,1634946243,5/12/2015 15:01:36,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[LOCATION],[LOCATION],PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR,n/a,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 15:06:36,1634950564,5/12/2015 15:05:30,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[LOCATION],[LOCATION],between the,N/A,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 15:26:29,1634974827,5/12/2015 15:26:06,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[OTHER],[OTHER],between the,N/A,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 15:59:12,1635016394,5/12/2015 15:58:32,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[LOCATION],[LOCATION],PERILYMPHATIC between the MIDDLE AND INNER EAR,N/A,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 17:25:16,1635060943,5/12/2015 17:24:29,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],can induce a between the,N/A,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 17:40:35,1635076154,5/12/2015 17:39:58,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[LOCATION],[LOCATION],a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR,N/a,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 17:46:23,1635082358,5/12/2015 17:45:04,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Large ambient pressure changes strenuous activities, induce PERILYMPHATIC FISTULA between MIDDLE INNER EAR",na,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 18:45:08,1635161025,5/12/2015 18:44:42,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 18:50:46,1635169793,5/12/2015 18:49:47,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],can induce,n/a,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 18:52:42,1635172866,5/12/2015 18:50:25,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],induce,n/a,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 18:58:51,1635182124,5/12/2015 18:58:17,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],induce,N/A,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 19:07:33,1635195452,5/12/2015 19:06:58,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[LOCATION],[LOCATION],can induce,N/A,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440570,5/12/2015 19:31:08,1635244270,5/12/2015 19:29:41,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[SIDE_EFFECT],[SIDE_EFFECT],"strenuous activities, can induce",n/a,127,93,-1,146,114,TWrex-cause,802374-FS1,"Large ambient pressure changes or strenuous activities, such as weight lifting, can induce a PERILYMPHATIC FISTULA between the MIDDLE AND INNER EAR",MIDDLE AND INNER EAR,PERILYMPHATIC FISTULA
720440571,5/12/2015 16:05:05,1635019779,5/12/2015 16:04:06,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PEPTIC ULCER; UPPER GASTROINTESTINAL TRACT;,N/A,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 17:46:39,1635082682,5/12/2015 17:45:52,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[NONE],[NONE],N/a,No relationship indicated in the sentence.,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 18:48:16,1635166023,5/12/2015 18:47:55,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 18:53:46,1635174178,5/12/2015 18:53:14,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[LOCATION],[LOCATION],Ulcers;,n.\/a,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 18:59:06,1635182515,5/12/2015 18:57:18,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],Ulcers;,n/a,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 19:06:18,1635193255,5/12/2015 19:05:04,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],activating factor;,N/A,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 19:17:00,1635215803,5/12/2015 19:14:24,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[OTHER],[OTHER],Ulcers; UPPER GASTROINTESTINAL TRACT;,N/A,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 19:43:32,1635259269,5/12/2015 19:43:20,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[IS_A],[IS_A],Ulcers;,n/a,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 19:51:04,1635264710,5/12/2015 19:50:39,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PAF; PEPTIC ULCER;,n/a,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 20:03:49,1635275658,5/12/2015 20:03:09,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PEPTIC ULCER; UPPER GASTROINTESTINAL TRACT;,N/A,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 20:16:48,1635285624,5/12/2015 20:15:02,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]","PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox ACP",N/A,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 20:48:07,1635306469,5/12/2015 20:46:47,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[NONE],[NONE],N/A,It's a list.,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 20:52:04,1635308768,5/12/2015 20:49:35,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[PART_OF] [NONE],"[PART_OF]
[NONE]",lcer disease,N/A,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 21:05:48,1635317543,5/12/2015 21:05:02,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[NONE],[NONE],n/a,"This is a list of things, not a relationship.",302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440571,5/12/2015 21:14:32,1635323175,5/12/2015 21:13:44,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,No apparent relation is evident.,302,5,-1,329,17,TWrex-cause,802771-FS1,"PAF; PEPTIC ULCER; Phosphorylcholine, acetyl glyceryl ether; Platelet activating factor; Polymox; Prilosec; Pylori gastritis; Pyloric obstruction; Pylorus; Recurrence; Recurrent bleeding; Stenosis, pylorus; Steroids; Tetracycline; TNF alpha; Trimox; Tumor necrosis factor alpha; Ulcer disease; Ulcers; UPPER GASTROINTESTINAL TRACT; Utimox; Wymox  ACP Journal Club.",UPPER GASTROINTESTINAL TRACT,PEPTIC ULCER
720440572,5/12/2015 09:54:11,1634760079,5/12/2015 09:53:36,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],to,Associated with,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 10:06:32,1634768546,5/12/2015 10:04:59,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"METASTATIC BASAL CELL CARCINOMA in GORLIN SY<span id=""transmark""></span>NDROME",n/a,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 10:34:07,1634792822,5/12/2015 10:33:48,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],to the bone,N/A,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 10:35:35,1634794642,5/12/2015 10:35:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",in,N/A,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 10:41:55,1634802979,5/12/2015 10:41:30,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],in,n/a,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 10:44:58,1634807020,5/12/2015 10:44:17,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],to the bone,none,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 11:05:55,1634829320,5/12/2015 11:04:57,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],to the bone in,n/a,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 11:17:32,1634838321,5/12/2015 11:17:17,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",to the bone in,N/A,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 11:25:31,1634842106,5/12/2015 11:25:17,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],SYNDROME,N/A,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 11:35:31,1634848600,5/12/2015 11:35:12,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],in,n/a,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 11:43:35,1634853342,5/12/2015 11:43:07,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[MANIFESTATION],[MANIFESTATION],in,I did not select 'none'.,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 12:39:57,1634879424,5/12/2015 12:39:27,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[MANIFESTATION],[MANIFESTATION],in,N/A,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 13:21:16,1634896393,5/12/2015 13:19:24,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,N/A,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 13:32:57,1634905421,5/12/2015 13:32:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],bone,n/a,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440572,5/12/2015 13:54:53,1634914390,5/12/2015 13:53:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[LOCATION],[LOCATION],to the bone,N/A,0,47,1,30,62,TWrex-cause,814113-FS1,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME
720440573,5/12/2015 20:04:49,1635276409,5/12/2015 20:04:13,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],more likely to occur with,n/a,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/12/2015 20:15:49,1635285005,5/12/2015 20:14:49,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEMORRHAGE likely to occur with OLIGODENDROGLIOMAS,N/A,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/12/2015 20:40:47,1635301593,5/12/2015 20:39:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]",HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,N/A,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/12/2015 21:19:28,1635326015,5/12/2015 21:19:14,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occur with,n/a,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/12/2015 21:31:17,1635332910,5/12/2015 21:30:41,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",occur with,N/A,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/12/2015 22:42:43,1635383936,5/12/2015 22:42:31,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS,N/A,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/12/2015 22:42:59,1635384120,5/12/2015 22:41:51,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],HEMORRHAGE likely occur OLIGODENDROGLIOMAS,N/A,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/12/2015 22:44:03,1635385000,5/12/2015 22:43:30,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CAUSES],[CAUSES],HEMORRHAGE likely to occur with OLIGODENDROGLIOMAS,N/A,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/13/2015 00:16:10,1635452258,5/13/2015 00:15:27,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],HEMORRHAGE is likely to occur with OLIGODENDROGLIOMAS,N/A,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/13/2015 00:32:21,1635463211,5/13/2015 00:31:35,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[MANIFESTATION],[MANIFESTATION],HEMORRHAGE is likely to occur with OLIGODENDROGLIOMAS,n/a,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/13/2015 00:33:43,1635464183,5/13/2015 00:33:21,false,elite,1.0,31848723,USA,"","",155.94.185.254,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEMORRHAGE OLIGODENDROGLIOMAS,N/A,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/13/2015 01:32:09,1635498964,5/13/2015 01:31:55,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is more likely to occur with,n/a,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/13/2015 02:09:09,1635519497,5/13/2015 02:08:42,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is more likely to occur with,N/A,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/13/2015 02:56:59,1635542000,5/13/2015 02:56:18,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is more likely to occur with,no comment,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440573,5/13/2015 03:05:55,1635545773,5/13/2015 03:05:33,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]",HEMORRHAGE to occur OLIGODENDROGLIOMAS,n/a,0,40,1,9,58,TWrex-cause,813388-FS1,HEMORRHAGE is more likely to occur with OLIGODENDROGLIOMAS than with astrocytomas.,HEMORRHAGE,OLIGODENDROGLIOMAS
720440574,5/12/2015 14:28:32,1634927797,5/12/2015 14:28:16,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],due to,N/A,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 14:38:26,1634932613,5/12/2015 14:38:14,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[CAUSES],[CAUSES],SYNCYTIAL,hjjj,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 14:46:59,1634936202,5/12/2015 14:46:40,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 14:55:38,1634940829,5/12/2015 14:54:57,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS,n/a,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 14:56:52,1634941693,5/12/2015 14:55:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],due to,N/A,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 15:23:18,1634970852,5/12/2015 15:23:01,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],due to,N/A,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 15:54:32,1635010624,5/12/2015 15:54:02,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS,N/A,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 17:15:59,1635055674,5/12/2015 17:15:39,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],due to,N/A,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 17:35:53,1635070793,5/12/2015 17:34:44,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[LOCATION],[LOCATION],PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS,N/a,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 17:39:59,1635075740,5/12/2015 17:39:28,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Economic impact PNEUMONIA RESPIRATORY SYNCYTIAL VIRUS infection.,na,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 18:37:32,1635148599,5/12/2015 18:35:15,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],infection.,n/a,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 18:40:13,1635153153,5/12/2015 18:39:59,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 18:46:53,1635163801,5/12/2015 18:46:36,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],due to,n/a,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 18:53:59,1635174492,5/12/2015 18:52:22,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],infection.,N/A,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440574,5/12/2015 19:03:14,1635188899,5/12/2015 19:02:41,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[CAUSES],[CAUSES],due to,N/A,19,36,1,27,63,TWrex-cause,810155-FS1,Economic impact of PNEUMONIA due to RESPIRATORY SYNCYTIAL VIRUS (RSV) infection.,PNEUMONIA,RESPIRATORY SYNCYTIAL VIRUS
720440575,5/12/2015 20:20:50,1635288455,5/12/2015 20:20:20,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MAGNESIUM SULPHATE with PRE ECLAMPSIA,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/12/2015 20:52:50,1635309236,5/12/2015 20:51:47,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/12/2015 21:27:26,1635330909,5/12/2015 21:27:04,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],trial,n/a,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/12/2015 21:38:39,1635336438,5/12/2015 21:37:48,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],for,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/12/2015 22:50:00,1635389441,5/12/2015 22:49:40,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],MAGNESIUM SULPHATE for PRE ECLAMPSIA,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/12/2015 23:10:14,1635405406,5/12/2015 23:08:39,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],MAGNESIUM SULPHATE for PRE ECLAMPSIA,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/13/2015 00:36:17,1635466078,5/13/2015 00:35:17,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/13/2015 00:38:25,1635467698,5/13/2015 00:37:42,false,elite,1.0,31848723,USA,"","",155.94.185.254,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MAGNESIUM SULPHATE PRE ECLAMPSIA,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/13/2015 00:55:15,1635479881,5/13/2015 00:53:35,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[TREATS],[TREATS],The Magpie Trial: randomised trial comparing MAGNESIUM SULPHATE with placebo PRE ECLAMPSIA,n/a,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/13/2015 02:13:25,1635521526,5/13/2015 02:12:58,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],comparing with placebo for,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/13/2015 03:02:39,1635544419,5/13/2015 03:02:15,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],with placebo for,no comment,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/13/2015 03:10:33,1635547890,5/13/2015 03:10:15,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],MAGNESIUM SULPHATE placebo for PRE ECLAMPSIA,n/a,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/13/2015 03:26:11,1635555025,5/13/2015 03:25:15,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],trial,n/a,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/13/2015 03:27:48,1635555680,5/13/2015 03:27:31,false,neodev,1.0,32087449,AUS,02,Sydney,203.31.216.214,[LOCATION],[LOCATION],comparing SULPHATE,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440575,5/13/2015 03:33:46,1635558332,5/13/2015 03:33:35,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],comparing MAGNESIUM SULPHATE placebo for ECLAMPSIA,N/A,83,47,-1,95,65,TWrex-cause,804677-FS1,The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
720440576,5/12/2015 14:23:30,1634925577,5/12/2015 14:23:06,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],Treatment of,N/A,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 14:37:03,1634931973,5/12/2015 14:36:53,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[LOCATION],[LOCATION],including,l;l;l;,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 14:45:16,1634935459,5/12/2015 14:45:05,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 14:48:32,1634936960,5/12/2015 14:46:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 14:49:09,1634937259,5/12/2015 14:48:38,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],NOCARDIA INFECTIONS caused by NOCARDIA,n/a,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 15:19:33,1634966435,5/12/2015 15:18:45,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],caused by,N/A,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 15:50:09,1635004598,5/12/2015 15:49:19,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],NOCARDIA INFECTIONS caused by NOCARDIA,N/A,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 15:57:46,1635014787,5/12/2015 15:57:05,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[PART_OF],[PART_OF],NOCARDIA INFECTIONS NOCARDIA,n/a,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 16:50:27,1635043244,5/12/2015 16:47:49,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 17:10:32,1635053494,5/12/2015 17:09:37,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PART_OF],[PART_OF],caused by,N/A,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 17:31:37,1635066290,5/12/2015 17:30:51,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[PART_OF],[PART_OF],NOCARDIA INFECTIONS Treatment of infections caused by NOCARDIA,N/a,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 17:38:15,1635073509,5/12/2015 17:38:03,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"NOCARDIA INFECTIONS Treatment infections caused NOCARDIA including asteroides, brasiliensis caviae.",na,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 18:22:22,1635127363,5/12/2015 18:20:10,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF],[PART_OF],caused by,N/A,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 18:38:31,1635150194,5/12/2015 18:38:16,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440576,5/12/2015 18:44:23,1635160044,5/12/2015 18:43:59,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",caused by NOCARDIA,n/a,5,5,1,23,13,TWrex-cause,812455-FS1,"121  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +   , including  N. asteroides, N. brasiliensis , and  N. caviae.",NOCARDIA INFECTIONS,NOCARDIA
720440577,5/12/2015 13:36:15,1634906804,5/12/2015 13:33:23,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],alternating,N/A,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 13:36:35,1634906960,5/12/2015 13:36:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,n/a,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 14:11:49,1634920691,5/12/2015 14:11:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],characterized by,N/A,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 14:26:55,1634927172,5/12/2015 14:26:16,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],BRADYCARDIA TACHYCARDIA SYNDROME is characterized by BRADYCARDIA,n/a,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 14:33:04,1634929838,5/12/2015 14:32:08,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],characterized by,N/A,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 14:33:48,1634930258,5/12/2015 14:33:33,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[CONTRAINDICATES],[CONTRAINDICATES],tachyarrhythmias,jjkk,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 14:36:12,1634931425,5/12/2015 14:35:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],BRADYCARDIA TACHYCARDIA SYNDROME characterized by BRADYCARDIA,n/a,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 14:36:31,1634931686,5/12/2015 14:35:07,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",characterized,N/A,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 14:41:22,1634933873,5/12/2015 14:41:02,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],characterized by,N/A,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 14:43:12,1634934594,5/12/2015 14:42:47,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],BRADYCARDIA TACHYCARDIA SYNDROME characterized atrial tachyarrhythmias atrial fibrillation) alternating periods BRADYCARDIA sinus pauses.,na,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 15:14:58,1634960224,5/12/2015 15:14:35,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],characterized by,N/A,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 15:31:32,1634980934,5/12/2015 15:31:14,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[SYMPTOM],[SYMPTOM],is characterized by,n/a,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 15:32:20,1634981962,5/12/2015 15:31:14,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],BRADYCARDIA TACHYCARDIA SYNDROME is characterized by periods of BRADYCARDIA,N/A,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 15:34:20,1634984579,5/12/2015 15:33:40,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CONTRAINDICATES],[CONTRAINDICATES],characterized,n/a,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440577,5/12/2015 15:38:35,1634989860,5/12/2015 15:37:51,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[SYMPTOM],[SYMPTOM],characterized by,N/A,4,4,1,14,36,TWrex-cause,812851-FS1,The BRADYCARDIA TACHYCARDIA SYNDROME is characterized by atrial tachyarrhythmias (usually atrial fibrillation) alternating with periods of BRADYCARDIA or sinus pauses.,BRADYCARDIA,BRADYCARDIA TACHYCARDIA SYNDROME
720440578,5/12/2015 09:52:36,1634759243,5/12/2015 09:51:42,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],as,Associated with,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 10:04:05,1634767086,5/12/2015 10:03:27,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[IS_A],[IS_A],"TRUNCAL OBESITY MALE PATTERN O<span id=""transmark""></span>BESITY)",n/a,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 10:32:29,1634791194,5/12/2015 10:32:08,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A],[IS_A],(also known as,N/A,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 10:33:11,1634791802,5/12/2015 10:32:13,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],(also known as,N/A,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 10:40:53,1634801704,5/12/2015 10:39:57,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[OTHER],[OTHER],(also known as,is the same as,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 10:43:17,1634804762,5/12/2015 10:42:35,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[OTHER],[OTHER],(also known as,none,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 11:03:57,1634826548,5/12/2015 11:03:41,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],(also known as,n/a,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 11:10:33,1634833997,5/12/2015 11:10:12,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],(also known as,n/a,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 11:16:52,1634838031,5/12/2015 11:16:33,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[IS_A],[IS_A],(also known as android or,N/A,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 11:23:50,1634841280,5/12/2015 11:23:20,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],OBESITY),N/A,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 11:34:02,1634847863,5/12/2015 11:33:38,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],(also known as,n/a,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 11:41:33,1634852138,5/12/2015 11:41:11,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[ASSOCIATED_WITH],[ASSOCIATED_WITH],correlates with,I did not select 'none'.,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 12:38:40,1634878741,5/12/2015 12:37:53,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[OTHER],[OTHER],(also known as,N/A,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 13:18:44,1634895146,5/12/2015 13:18:03,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],(also known as,N/A,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440578,5/12/2015 13:32:13,1634904958,5/12/2015 13:31:57,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],manifested,n/a,42,0,1,61,15,TWrex-cause,814118-FS1,"TRUNCAL OBESITY (also known as android or MALE PATTERN OBESITY) manifested as a high waist to hip ratio, correlates with higher LDL and lower HDL levels.",MALE PATTERN OBESITY,TRUNCAL OBESITY
720440579,5/12/2015 09:48:39,1634756491,5/12/2015 09:47:54,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],by,Associated with,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 09:57:07,1634762356,5/12/2015 09:56:29,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[CAUSES],[CAUSES],"LISTERIA INFECTIONS caused by LISTERIA MONOC<span id=""transmark""></span>YTOGENES",n/a,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 10:26:08,1634783784,5/12/2015 10:23:49,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF],[PART_OF],LISTERIA INFECTIONS,N/A,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 10:29:22,1634787671,5/12/2015 10:28:52,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Treatment,N/A,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 10:37:31,1634797187,5/12/2015 10:37:08,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused by,n/a,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 10:38:26,1634798425,5/12/2015 10:38:01,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 11:01:02,1634822245,5/12/2015 11:00:36,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 11:08:56,1634832899,5/12/2015 11:08:40,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 11:13:36,1634836043,5/12/2015 11:12:21,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[CAUSES],[CAUSES],caused by,N/A,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 11:21:15,1634840182,5/12/2015 11:21:03,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],infections,N/A,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 11:27:36,1634843505,5/12/2015 11:27:09,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 11:38:14,1634850057,5/12/2015 11:37:49,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],Treatment of infections caused by,I did not select 'none'.,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 12:12:25,1634867013,5/12/2015 12:11:38,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[CAUSES],[CAUSES],caused by,N/A,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 13:11:52,1634892386,5/12/2015 13:10:11,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440579,5/12/2015 13:30:30,1634903500,5/12/2015 13:30:14,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment of,n/a,4,60,1,22,82,TWrex-cause,810950-FS1,11  LISTERIA INFECTIONS  Treatment of infections caused by  LISTERIA MONOCYTOGENES ; used alone or in conjunction with an aminoglycoside.,LISTERIA INFECTIONS,LISTERIA MONOCYTOGENES
720440580,5/12/2015 14:29:13,1634928037,5/12/2015 14:28:32,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],Used alone or in combination,N/A,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 14:38:46,1634932792,5/12/2015 14:38:33,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[LOCATION],[LOCATION],HYPERTENSION,hjhjhj,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 14:47:20,1634936360,5/12/2015 14:47:00,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],for,N/A,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 14:56:57,1634941753,5/12/2015 14:55:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CLONIDINE Used for all stages of HYPERTENSION,n/a,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 14:58:10,1634942724,5/12/2015 14:56:54,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],Used alone or in combination,N/A,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 15:23:51,1634971613,5/12/2015 15:23:19,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],Used for,N/A,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 15:55:26,1635011851,5/12/2015 15:54:33,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],CLONIDINE HYDROCHLORIDE Used alone for HYPERTENSION,N/A,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 17:17:25,1635056408,5/12/2015 17:16:00,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Used alone or in combination with other,N/A,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 17:36:33,1635071555,5/12/2015 17:35:55,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],CLONIDINE HYDROCHLORIDE with other antihypertensive agents for all stages of HYPERTENSION,N/a,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 17:41:07,1635076748,5/12/2015 17:40:01,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Thiazide Diuretics Synonyms: Chlorthalidone Atenolol; Chlorthalidone CLONIDINE HYDROCHLORIDE Uses Hypertension Used alone combination other antihypertensive agents stages HYPERTENSION,na,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 18:40:34,1635153698,5/12/2015 18:40:17,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 18:45:12,1635161170,5/12/2015 18:44:45,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Uses,n/a,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 18:47:24,1635164753,5/12/2015 18:46:55,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],Uses Hypertension Used,n/a,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 18:55:06,1635176209,5/12/2015 18:54:01,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",combination with other,N/A,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440580,5/12/2015 19:04:08,1635190077,5/12/2015 19:03:16,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[TREATS],[TREATS],Used alone or in combination with other antihypertensive agents,N/A,240,113,-1,251,136,TWrex-cause,803987-FS1,Class:  Thiazide like Diuretics 40:28.24; CV701 (VA)  Synonyms:  Chlorthalidone and Atenolol; Chlorthalidone and CLONIDINE HYDROCHLORIDE  Uses  Hypertension  Used alone or in combination with other antihypertensive agents for all stages of HYPERTENSION,HYPERTENSION,CLONIDINE HYDROCHLORIDE
720440581,5/12/2015 19:31:57,1635245161,5/12/2015 19:31:23,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[OTHER],[OTHER],reduced the prevalence,N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/12/2015 19:56:56,1635270076,5/12/2015 19:56:38,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/12/2015 20:01:53,1635274127,5/12/2015 19:59:31,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],zinc with vitamin A reduced,n/a,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/12/2015 20:12:42,1635282665,5/12/2015 20:12:05,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(DIARRHEA and DYSENTERY,N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/12/2015 20:37:04,1635299291,5/12/2015 20:35:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]","However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/12/2015 21:17:57,1635325183,5/12/2015 21:17:22,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],stools),n/a,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/12/2015 21:27:39,1635330996,5/12/2015 21:26:55,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/12/2015 22:37:54,1635380254,5/12/2015 22:36:35,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],zinc reduced prevalence persistent diarrhea and DYSENTERY,N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/12/2015 22:39:51,1635381639,5/12/2015 22:39:20,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reduced the prevalence of persistent (DIARRHEA and DYSENTERY,N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/12/2015 22:42:28,1635383753,5/12/2015 22:41:33,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[SYMPTOM] [ASSOCIATED_WITH] [IS_A],"[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]",persistent diarrhea DYSENTERY,N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/13/2015 00:09:07,1635447496,5/13/2015 00:08:28,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],in prevalence of persistent diarrhea DYSENTERY,N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/13/2015 00:29:38,1635461273,5/13/2015 00:28:58,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],zinc with vitamin A reduced persistent diarrhea (DIARRHEA lasting ‚â• 14 d) and DYSENTERY,n/a,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/13/2015 00:32:39,1635463446,5/13/2015 00:32:18,false,elite,1.0,31848723,USA,"","",155.94.185.254,[TREATS],[TREATS],(DIARRHEA DYSENTERY,N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/13/2015 01:29:41,1635497728,5/13/2015 01:28:15,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[OTHER],[OTHER],in,there is no relation between the two terms. they are referencing the same thing,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440581,5/13/2015 02:06:10,1635517895,5/13/2015 02:05:35,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,91,155,1,98,164,TWrex-cause,814915-FS1,"However, zinc in combination with vitamin A reduced the prevalence of persistent diarrhea (DIARRHEA lasting ‚â• 14 d) (rate ratio 0.79, CI 0.66 to 0.94) and DYSENTERY (blood and mucus in stools) (rate ratio 0.80, CI 0.67 to 0.95.",DIARRHEA,DYSENTERY
720440582,5/12/2015 19:57:17,1635270405,5/12/2015 19:56:57,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],in HYPERTENSION,n/a,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/12/2015 20:02:27,1635274608,5/12/2015 20:01:55,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PART_OF],[PART_OF],in,n/a,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/12/2015 20:13:44,1635283425,5/12/2015 20:12:43,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[NONE],[NONE],N/A,It's not a complete enough excerpt to be able to tell for sure what it is.,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/12/2015 20:38:10,1635299983,5/12/2015 20:37:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",N/A,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/12/2015 21:18:53,1635325780,5/12/2015 21:17:58,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[NONE],[NONE],n/a,Gotzsche PC is an author or something.,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/12/2015 21:28:40,1635331513,5/12/2015 21:27:40,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,First term is the author of the study.,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/12/2015 22:40:38,1635382267,5/12/2015 22:37:55,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],GOTZSCHE PC in HYPERTENSION,N/A,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/12/2015 22:40:48,1635382424,5/12/2015 22:39:52,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[NONE],[NONE],N/A,Author of article,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/12/2015 22:43:00,1635384142,5/12/2015 22:42:29,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],GOTZSCHE PC in HYPERTENSION,N/A,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/13/2015 00:11:36,1635449034,5/13/2015 00:09:08,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",N/A,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/13/2015 00:30:26,1635461903,5/13/2015 00:29:40,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[NONE],[NONE],n/a,there is no thought or sentence here..just words,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/13/2015 00:32:57,1635463680,5/13/2015 00:32:41,false,elite,1.0,31848723,USA,"","",155.94.185.254,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",GOTZSCHE HYPERTENSION,N/A,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/13/2015 01:30:55,1635498280,5/13/2015 01:29:42,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[NONE],[NONE],n/a,The first term is the name of a person,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/13/2015 02:07:24,1635518639,5/13/2015 02:06:11,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in,N/A,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440582,5/13/2015 02:55:37,1635541405,5/13/2015 02:54:02,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[NONE],[NONE],N/A,no comment,82,0,1,93,11,TWrex-cause,812618-FS1,"GOTZSCHE PC Safar M, Helgeland A. Enalapril, atenolol, and hydrochlorothiazide in HYPERTENSION",HYPERTENSION,GOTZSCHE PC
720440583,5/12/2015 09:34:44,1634745277,5/12/2015 09:32:51,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 09:38:18,1634747921,5/12/2015 09:37:24,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[ASSOCIATED_WITH] [PART_OF] [OTHER],"[ASSOCIATED_WITH]
[PART_OF]
[OTHER]","CHLORIDE CHANNEL DISORDERS include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen dis<span id=""transmark""></span>ease),",n/a,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 09:39:21,1634748723,5/12/2015 09:38:34,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 09:39:33,1634748935,5/12/2015 09:38:49,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,Associated,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 10:08:26,1634769709,5/12/2015 10:06:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 10:16:40,1634775128,5/12/2015 10:15:39,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 10:20:11,1634778150,5/12/2015 10:19:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 10:28:55,1634787155,5/12/2015 10:27:46,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],associated,none,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 10:50:53,1634811472,5/12/2015 10:50:30,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is often associated with,N/A,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 10:51:26,1634811890,5/12/2015 10:50:53,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is often associated with,n/a,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 11:05:13,1634828333,5/12/2015 11:04:55,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 11:15:31,1634837238,5/12/2015 11:15:10,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],MUSCLE HYPERTROPHY,N/A,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 11:25:40,1634842164,5/12/2015 11:25:17,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is often associated with,I did not select 'none'.,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 11:55:37,1634859597,5/12/2015 11:55:14,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440583,5/12/2015 12:04:02,1634863336,5/12/2015 12:03:14,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,199,72,1,216,109,TWrex-cause,814083-FS1,"71 , 72  CHLORIDE CHANNEL DISORDERS  Chloride channel disorders include AUTOSOMAL DOMINANT MYOTONIA CONGENITA (Thomsen disease), which occurs in the first decade of life and is often associated with MUSCLE HYPERTROPHY and autosomal recessive myotonia congenita (Becker type myotonia) (BMD), which comes later in life and can be more severe.",MUSCLE HYPERTROPHY,AUTOSOMAL DOMINANT MYOTONIA CONGENITA
720440584,5/12/2015 14:26:16,1634926832,5/12/2015 14:25:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 14:37:35,1634932146,5/12/2015 14:37:25,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],versus,;'',124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 14:45:52,1634935686,5/12/2015 14:45:37,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 14:51:39,1634938552,5/12/2015 14:50:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,N/A,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 14:52:11,1634938839,5/12/2015 14:50:46,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],WARFARIN in treatment of ACUTE VENOUS THROMBOEMBOLISM,n/a,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 15:21:57,1634969143,5/12/2015 15:21:36,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment of,N/A,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 15:52:43,1635007979,5/12/2015 15:51:27,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],versus WARFARIN in treatment of ACUTE VENOUS THROMBOEMBOLISM,N/A,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 17:12:57,1635054547,5/12/2015 17:11:57,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],in the treatment of,N/A,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 17:32:57,1635067730,5/12/2015 17:32:33,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,N/a,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 17:38:51,1635074350,5/12/2015 17:38:38,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Dabigatran versus WARFARIN treatment ACUTE VENOUS THROMBOEMBOLISM,na,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 18:24:12,1635130197,5/12/2015 18:23:42,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 18:34:12,1635144102,5/12/2015 18:33:58,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 18:39:15,1635151411,5/12/2015 18:39:00,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 18:45:11,1635161105,5/12/2015 18:44:48,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment of,n/a,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440584,5/12/2015 18:49:22,1635167736,5/12/2015 18:48:57,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,124,95,-1,151,103,TWrex-cause,804041-FS1,"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM",ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
720440585,5/12/2015 14:19:23,1634923762,5/12/2015 14:18:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],such as,N/A,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 14:36:43,1634931810,5/12/2015 14:36:31,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[CAUSES],[CAUSES],"causes,",;;;,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 14:45:04,1634935344,5/12/2015 14:44:44,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 14:46:41,1634936086,5/12/2015 14:45:06,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],such as,N/A,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 14:48:32,1634936962,5/12/2015 14:47:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,n/a,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 14:48:51,1634937073,5/12/2015 14:48:34,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Evidence: recent review establishes opinion experts CPP potential causes, many cases similar other IDIOPATHIC PAIN CONDITIONS such FIBROMYALGIA",na,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 15:18:44,1634965388,5/12/2015 15:18:28,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],such as,N/A,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 15:49:17,1635003451,5/12/2015 15:48:27,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[IS_A],[IS_A],IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,N/A,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 15:57:03,1635013884,5/12/2015 15:56:15,false,prodege,1.0,14571439,CAN,ON,Toronto,142.20.20.193,[PART_OF],[PART_OF],such as,n/a,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 16:47:47,1635041728,5/12/2015 16:47:18,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such,n/a,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 17:09:34,1635052942,5/12/2015 17:07:49,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PART_OF],[PART_OF],many cases,N/A,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 17:29:15,1635064196,5/12/2015 17:28:38,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[IS_A],[IS_A],IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,N/a,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 18:20:08,1635124423,5/12/2015 18:19:25,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF],[PART_OF],such as,N/A,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 18:38:12,1635149729,5/12/2015 18:37:55,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440585,5/12/2015 18:43:59,1635159407,5/12/2015 18:43:11,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[SYMPTOM],[SYMPTOM],"potential causes,",n/a,140,175,1,165,187,TWrex-cause,813151-FS1,"Evidence: ‚Ä¢ A recent review establishes that in the opinion of experts CPP has many potential causes, but in many cases is similar to other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA ( 20.",IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
720440586,5/12/2015 19:11:26,1635201614,5/12/2015 19:10:17,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[MANIFESTATION],[MANIFESTATION],suspected,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 19:25:10,1635234870,5/12/2015 19:24:29,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[MANIFESTATION],[MANIFESTATION],suspected in patients,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 19:53:09,1635266369,5/12/2015 19:51:32,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],is suspected in patients with,n/a,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 19:54:22,1635267507,5/12/2015 19:54:06,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],suspected in patients,n/a,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 20:09:05,1635279566,5/12/2015 20:08:43,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[SYMPTOM],[SYMPTOM],FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 20:27:57,1635293620,5/12/2015 20:26:37,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 21:09:30,1635319944,5/12/2015 21:08:46,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],suspected,n/a,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 21:20:46,1635326809,5/12/2015 21:19:52,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",in patients with,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 22:15:36,1635361393,5/12/2015 22:14:37,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings;,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 22:16:08,1635361886,5/12/2015 22:15:29,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 22:36:56,1635379601,5/12/2015 22:36:33,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 22:37:30,1635380021,5/12/2015 22:36:56,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[SYMPTOM],[SYMPTOM],FIBROMYALGIA suspected in patients with GENERALIZED PAIN AND TENDERNESS,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 23:01:18,1635398487,5/12/2015 23:00:47,false,clixsense,1.0,19294877,USA,MA,Boston,71.174.182.224,[SYMPTOM],[SYMPTOM],FIBROMYALGIA is suspected patients with GENERALIZED PAIN AND TENDERNESS,n/a,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 23:40:06,1635427603,5/12/2015 23:39:21,false,neodev,1.0,31294288,GBR,V2,Glasgow,92.0.224.52,[LOCATION] [CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[LOCATION]
[ASSOCIATED_WITH]",is suspected in patients with,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440586,5/12/2015 23:45:05,1635431386,5/12/2015 23:42:23,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],GENERALIZED PAIN AND TENDERNESS is symptom.,N/A,43,0,1,73,12,TWrex-cause,814000-FS1,FIBROMYALGIA is suspected in patients with GENERALIZED PAIN AND TENDERNESS especially disproportionate to the physical findings; with negative laboratory results despite widespread symptoms; or when fatigue is the predominant symptom.,GENERALIZED PAIN AND TENDERNESS,FIBROMYALGIA
720440587,5/12/2015 14:29:28,1634928184,5/12/2015 14:29:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],therapy for,N/A,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 14:39:15,1634932923,5/12/2015 14:39:03,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[SYMPTOM],[SYMPTOM],OSTEOMYELITIS,yyuu,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 14:47:32,1634936436,5/12/2015 14:47:21,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 14:57:20,1634941986,5/12/2015 14:56:58,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CIPROFLOXACIN therapy for OSTEOMYELITIS,n/a,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 14:59:29,1634943838,5/12/2015 14:58:11,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy for,N/A,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 15:24:28,1634972328,5/12/2015 15:23:53,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],therapy for,N/A,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 15:55:57,1635012435,5/12/2015 15:55:29,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],CIPROFLOXACIN therapy for OSTEOMYELITIS,N/A,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 17:19:31,1635057356,5/12/2015 17:17:29,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],therapy for,N/A,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 17:36:51,1635071923,5/12/2015 17:36:34,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],CIPROFLOXACIN therapy for OSTEOMYELITIS,N/a,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 17:43:09,1635078815,5/12/2015 17:41:15,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Oral CIPROFLOXACIN therapy OSTEOMYELITIS caused aerobic gram negative bacilli.,na,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 18:40:56,1635154252,5/12/2015 18:40:38,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 18:46:04,1635162588,5/12/2015 18:45:23,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],therapy,n/a,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 18:48:11,1635165896,5/12/2015 18:47:53,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],therapy for,n/a,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 18:55:26,1635176758,5/12/2015 18:55:07,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],therapy,N/A,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440587,5/12/2015 19:04:32,1635190641,5/12/2015 19:04:09,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[TREATS],[TREATS],therapy,N/A,68,42,-1,80,55,TWrex-cause,800243-FS1,"Slama TG, Misinski J, Sklar S et al. Oral CIPROFLOXACIN therapy for OSTEOMYELITIS caused by aerobic gram negative bacilli.",OSTEOMYELITIS,CIPROFLOXACIN
720440588,5/12/2015 14:39:37,1634933126,5/12/2015 14:39:22,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[LOCATION],[LOCATION],CARIES,jkk,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 14:47:46,1634936645,5/12/2015 14:47:34,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],prevention,N/A,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 14:58:29,1634943034,5/12/2015 14:57:21,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],SODIUM FLUORIDE prevention of DENTAL CARIES,n/a,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 15:01:19,1634945351,5/12/2015 14:59:31,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],for prevention,N/A,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 15:24:52,1634972824,5/12/2015 15:24:33,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS],[PREVENTS],prevention,N/A,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 15:56:38,1635013334,5/12/2015 15:55:58,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PREVENTS],[PREVENTS],SODIUM FLUORIDE prevention of DENTAL CARIES,N/A,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 17:21:25,1635058386,5/12/2015 17:19:33,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PREVENTS],[PREVENTS],for prevention,N/A,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 17:37:15,1635072269,5/12/2015 17:36:53,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[PREVENTS],[PREVENTS],SODIUM FLUORIDE for prevention of DENTAL CARIES,N/a,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 17:43:58,1635079765,5/12/2015 17:43:10,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],tablet SODIUM FLUORIDE prevention DENTAL CARIES osteoporosis.,na,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 18:41:45,1635155466,5/12/2015 18:41:01,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 18:46:39,1635163354,5/12/2015 18:46:09,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],prevention,n/a,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 18:48:40,1635166677,5/12/2015 18:48:12,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",prevention of,n/a,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 18:55:41,1635177161,5/12/2015 18:55:28,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],prevention,N/A,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 19:04:58,1635191199,5/12/2015 19:04:33,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[PREVENTS],[PREVENTS],prevention,N/A,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440588,5/12/2015 19:16:59,1635215755,5/12/2015 19:16:24,false,getpaid,1,31508257,CAN,QC,Gatineau,70.82.102.20,[PREVENTS],[PREVENTS],for prevention,N/a,46,12,-1,58,27,TWrex-cause,804567-FS1,A tablet of SODIUM FLUORIDE for prevention of DENTAL CARIES and osteoporosis.,DENTAL CARIES,SODIUM FLUORIDE
720440589,5/12/2015 09:56:41,1634762070,5/12/2015 09:55:33,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],Resistant,Resistance to,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 10:11:21,1634771790,5/12/2015 10:10:18,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[SIDE_EFFECT] [PART_OF],"[SIDE_EFFECT]
[PART_OF]","SCABIES Overuse notably LIN<span id=""transmark""></span>DANE",n/a,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 10:35:25,1634794375,5/12/2015 10:35:03,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT],[SIDE_EFFECT],Overuse and misuse,N/A,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 10:41:22,1634802285,5/12/2015 10:40:16,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],"scabicides, notably",N/A,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 10:47:12,1634809023,5/12/2015 10:46:43,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CONTRAINDICATES],[CONTRAINDICATES],decreased efficacy.,none,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 10:51:55,1634812172,5/12/2015 10:51:24,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],Overuse misuse,n/a,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 11:07:43,1634831951,5/12/2015 11:07:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],"misuse of scabicides, have decreased their efficacy.",n/a,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 11:18:54,1634838976,5/12/2015 11:18:30,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],Overuse and misuse of LINDANE have decreased efficacy.,N/A,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 11:31:39,1634846378,5/12/2015 11:29:34,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],SCABIES,N/A,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 11:37:46,1634849836,5/12/2015 11:37:15,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],"scabicides,",n/a,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 11:47:05,1634855303,5/12/2015 11:45:19,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,It does not seem to belong to the same sentence.,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 12:42:05,1634880531,5/12/2015 12:41:39,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],"scabicides,",N/A,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 13:25:14,1634898913,5/12/2015 13:23:39,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],Overuse and misuse,N/A,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 13:34:04,1634905872,5/12/2015 13:33:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CONTRAINDICATES],[CONTRAINDICATES],misuse,n/a,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440589,5/12/2015 14:01:10,1634916750,5/12/2015 14:00:30,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS] [OTHER],"[TREATS]
[OTHER]",Overuse misuse,Potentially NOT TREAT if it doesn't work anymore because of misuse.,13,72,-1,19,79,TWrex-cause,804844-FS1,"3  Resistant SCABIES  Overuse and misuse of certain scabicides, notably LINDANE have decreased their efficacy.",SCABIES,LINDANE
720440590,5/12/2015 14:40:52,1634933589,5/12/2015 14:40:33,false,elite,1.0,31913360,USA,DE,"",108.59.8.208,[LOCATION],[LOCATION],led,hjhj,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 14:48:55,1634937131,5/12/2015 14:48:29,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],led to the description of,N/A,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 15:01:34,1634945584,5/12/2015 15:00:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DEXTROCARDIA led to KARTAGENER SYNDROME,n/a,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 15:05:29,1634949377,5/12/2015 15:03:57,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],and DEXTROCARDIA led to the description of,N/A,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 15:26:05,1634974345,5/12/2015 15:25:39,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],led to the description of,N/A,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 15:58:31,1635015742,5/12/2015 15:58:02,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],DEXTROCARDIA description of KARTAGENER SYNDROME,N/A,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 17:24:28,1635060306,5/12/2015 17:23:24,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[OTHER],[OTHER],led to the description,N/A,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 17:39:56,1635075643,5/12/2015 17:39:24,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[SYMPTOM],[SYMPTOM],DEXTROCARDIA led to the description of KARTAGENER SYNDROME,N/a,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 17:45:02,1635081046,5/12/2015 17:44:36,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"discovery cohort people sinusitis, bronchiectasis, DEXTROCARDIA description KARTAGENER SYNDROME",na,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 18:44:38,1635160515,5/12/2015 18:44:19,false,neodev,1.0,32103286,GBR,H9,London,193.109.199.16,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 18:49:46,1635168400,5/12/2015 18:49:26,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],led to the,n/a,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 18:50:25,1635169253,5/12/2015 18:48:33,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PART_OF],[PART_OF],discovery,n/a,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 18:58:16,1635181151,5/12/2015 18:57:34,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],led,N/A,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 19:06:54,1635194238,5/12/2015 19:06:07,false,elite,1.0,30064988,GBR,H3,Leeds,92.29.156.184,[SYMPTOM],[SYMPTOM],led to the description,N/A,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
720440590,5/12/2015 19:29:40,1635242161,5/12/2015 19:27:17,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[SYMPTOM],[SYMPTOM],discovery of a cohort led to the description,n/a,81,120,1,92,139,TWrex-cause,813677-FS1,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME
